{"content":"<li class=\"n-box-item date-title\" data-end=\"1368763199\" data-start=\"1368676800\" data-txt=\"Friday, December 20, 2019\">Thursday, May 16, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1031361\" data-ts=\"1368748447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1031361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Some notes from the J.C. Penney (NYSE:JCP) Q1 earnings call: CEO Mike Ullman has identified 30...</a></h4><p>Some notes from the J.C. Penney (NYSE:<a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a>) Q1 earnings call: CEO Mike Ullman has identified 30 to 40 areas to improve, adding that he doesn't see any structural issues that would prevent a turnaround and thinks margin will return to 2011 levels. He notes that 2013 CAPEX spending is nearing completion, and he plans to bring back 3 or 4 private label brands. Read more on <a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a>'s earnings call here: <a href=\"https://seekingalpha.com/article/1442071-j-c-penney-s-ceo-discusses-q1-2013-results-earnings-call-transcript\" target=\"_blank\">Earnings Call Transcript</a>. Shares <font color=\"red\">-1.7%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1031361\" data-linked=\"Some notes from the J.C. Penney (NYSE:JCP) Q1 earnings call: CEO Mike Ullman has identified 30...\" data-tweet=\"$JCP - Some notes from the J.C. Penney (NYSE:JCP) Q1 earnings call: CEO Mike Ullman has identified 30 to 40 areas to improve, adding that he doesn&#39;t see any structural issues that would prevent a turnaround and thinks margin will return to 2011 levels. ... https://seekingalpha.com/news/1031361?source=tweet\" data-url=\"https://seekingalpha.com/news/1031361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1031301\" data-ts=\"1368743693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSAT\" target=\"_blank\">VSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1031301\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Viasat (NASDAQ:VSAT): Q4 revenue beats consensus as total sales grow by 28% Y/Y on...</a></h4><p>More on Viasat (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VSAT\" title=\"Viasat, Inc.\">VSAT</a>): <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/1031091\">Q4 revenue beats consensus</a> as total sales grow by 28% Y/Y on strong top line growth across all our business segments, including Government Systems despite severe budget pressures. Steady gains in Exede satellite broadband subscribers coupled with 36% growth in contract awards pushed revenues up 30% to over the $1B mark for FY13. Shares <font color=\"green\">+1.7%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1031301\" data-linked=\"More on Viasat (NASDAQ:VSAT): Q4 revenue beats consensus as total sales grow by 28% Y/Y on...\" data-tweet=\"$VSAT - More on Viasat (NASDAQ:VSAT): Q4 revenue beats consensus as total sales grow by 28% Y/Y on strong top line growth across all our business segments, including Government Systems despite severe budget pressures. Steady gains in Exede satellite bro... https://seekingalpha.com/news/1031301?source=tweet\" data-url=\"https://seekingalpha.com/news/1031301\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1031171\" data-ts=\"1368740505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SINA\" target=\"_blank\">SINA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1031171\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 5:15 p.m.: SINA +4.7%. EA +2.7%. NBG +2.5%. AKAM +2.4%. DYAX...</a></h4><b>After-hours top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/SINA' title='Sina Corporation'>SINA</a> <font color=\"green\">+4.7%</font>. <a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a> <font color=\"green\">+2.7%</font>. NBG <font color=\"green\">+2.5%</font>. <a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a> <font color=\"green\">+2.4%</font>. <a href='https://seekingalpha.com/symbol/DYAX' title='Dyax Corp.'>DYAX</a> <font color=\"green\">+2.4%</font>. <br /> <b>After-hours top losers:</b> <a href='https://seekingalpha.com/symbol/ARUN' title='Aruba Networks, Inc.'>ARUN</a> <font color=\"red\">-13.7%</font>. <a href='https://seekingalpha.com/symbol/ADSK' title='Autodesk, Inc.'>ADSK</a> <font color=\"red\">-5.2%</font>. <a href='https://seekingalpha.com/symbol/BRCD' title='Brocade Communications Systems, Inc.'>BRCD</a> <font color=\"red\">-4.9%</font>. <a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a> <font color=\"red\">-3.5%</font>. <a href='https://seekingalpha.com/symbol/EGLE' title='Eagle Bulk Shipping Inc.'>EGLE</a> <font color=\"red\">-2.4%</font>.<div class=\"tiny-share-widget\" data-id=\"1031171\" data-linked=\"After-hours top gainers, as of 5:15 p.m.: SINA +4.7%. EA +2.7%. NBG +2.5%. AKAM +2.4%. DYAX...\" data-tweet=\"$SINA $SINA $EA - After-hours top gainers, as of 5:15 p.m.: SINA +4.7%. EA +2.7%. NBG +2.5%. AKAM +2.4%. DYAX +2.4%. After-hours top losers: ARUN -13.7%. ADSK -5.2%. BRCD -4.9%. JWN -3.5%. EGLE -2.4%. https://seekingalpha.com/news/1031171?source=tweet\" data-url=\"https://seekingalpha.com/news/1031171\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1031161\" data-ts=\"1368740326\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARUN\" target=\"_blank\">ARUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1031161\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aruba (NASDAQ:ARUN) -16.2% AH after guiding on its FQ3 call for FQ4 revenue $148M-$150M and EPS...</a></h4><p>Aruba (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARUN\" title=\"Aruba Networks, Inc.\">ARUN</a>) <font color=\"red\">-16.2%</font> AH after <a href=\"http://www.streetinsider.com/Earnings/UPDATE%3A+Aruba+Networks%2C+Inc.+%28ARUN%29+Misses+Q3+EPS+by+4c%2C+Guidance+Light/8347955.html\" target=\"_blank\">guiding</a> on its <a href=\"https://seekingalpha.com/currents/post/1030801\" target=\"_blank\">FQ3</a> call for FQ4 revenue $148M-$150M and EPS of $0.10-$0.12, below a consensus of $157.1M and $0.17. <a href=\"https://twitter.com/TechStockRadar/status/335137747541049345\" target=\"_blank\">Management admits</a> it's seeing tougher competition from Cisco (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CSCO\" title=\"Cisco Systems, Inc.\">CSCO</a>), which is now bundling its Wi-Fi solutions with its routers and data center products - <a href=\"https://seekingalpha.com/currents/post/1028361\" target=\"_blank\">Cisco just reported</a> 27% Y/Y growth for April quarter Wi-Fi sales. Aruba now <font color=\"red\">-34%</font> since its <a href=\"https://seekingalpha.com/currents/post/1004581\" target=\"_blank\">May 7 warning</a>.</p><div class=\"tiny-share-widget\" data-id=\"1031161\" data-linked=\"Aruba (NASDAQ:ARUN) -16.2% AH after guiding on its FQ3 call for FQ4 revenue $148M-$150M and EPS...\" data-tweet=\"$ARUN $ARUN $CSCO - Aruba (NASDAQ:ARUN) -16.2% AH after guiding on its FQ3 call for FQ4 revenue $148M-$150M and EPS of $0.10-$0.12, below a consensus of $157.1M and $0.17. Management admits it&#39;s seeing tougher competition from Cisco (NASDAQ:CSCO), which... https://seekingalpha.com/news/1031161?source=tweet\" data-url=\"https://seekingalpha.com/news/1031161\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1031151\" data-ts=\"1368739879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1031151\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Nordstrom (NYSE:JWN): Q1 misses across the board. Net earnings fell 2.7% Y/Y as higher...</a></h4><p>More on Nordstrom (NYSE:<a href=\"https://seekingalpha.com/symbol/JWN\" title=\"Nordstrom Inc.\">JWN</a>): <a href=\"https://seekingalpha.com/market_currents/post/1031131\" target=\"_blank\">Q1 misses across the board</a>. Net earnings fell 2.7% Y/Y as higher input costs masked slightly better revenue. The company also cut its FY14 total sales and same-store sales guidance ranges by half a percentage point each, now expecting 4% to 6% growth, and 3% to 5% growth, respectively. For the current period, it projects its EPS to grow by more than 7%, or around $0.86, just below the $0.87 projected by analysts. Shares <font color=\"red\">-3.5%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1031151\" data-linked=\"More on Nordstrom (NYSE:JWN): Q1 misses across the board. Net earnings fell 2.7% Y/Y as higher...\" data-tweet=\"$JWN - More on Nordstrom (NYSE:JWN): Q1 misses across the board. Net earnings fell 2.7% Y/Y as higher input costs masked slightly better revenue. The company also cut its FY14 total sales and same-store sales guidance ranges by half a percentage point e... https://seekingalpha.com/news/1031151?source=tweet\" data-url=\"https://seekingalpha.com/news/1031151\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1031091\" data-ts=\"1368738935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSAT\" target=\"_blank\">VSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1031091\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ViaSat (NASDAQ:VSAT): FQ4 EPS of $0.19. Revenue of $308.7M beats by $23.53M. Shares +1.1% AH. (PR)</a></h4><b>ViaSat (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VSAT\" title=\"Viasat, Inc.\">VSAT</a>):</b> FQ4 EPS of $0.19. Revenue of $308.7M <font color=\"green\">beats by $23.53M</font>. Shares  <font color=\"green\">+1.1%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1031091\" data-linked=\"ViaSat (NASDAQ:VSAT): FQ4 EPS of $0.19. Revenue of $308.7M beats by $23.53M. Shares +1.1% AH. (PR)\" data-tweet=\"$VSAT - ViaSat (NASDAQ:VSAT): FQ4 EPS of $0.19. Revenue of $308.7M beats by $23.53M. Shares +1.1% AH. (PR) https://seekingalpha.com/news/1031091?source=tweet\" data-url=\"https://seekingalpha.com/news/1031091\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1031071\" data-ts=\"1368738526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SINA\" target=\"_blank\">SINA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1031071\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sina (NASDAQ:SINA): Q1 EPS of $0.02 beats by $0.05. Revenue of $126M (+19% Y/Y) beats by $8.5M....</a></h4><b>Sina (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SINA\" title=\"Sina Corporation\">SINA</a>):</b> Q1 EPS of $0.02 <font color=\"green\">beats by $0.05</font>. Revenue of $126M (+19% Y/Y) <font color=\"green\">beats by $8.5M</font>. Expects Q2 revenue of $143M-$147M, above $142.7M consensus. Shares <font color=\"green\">+4.6%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1031071\" data-linked=\"Sina (NASDAQ:SINA): Q1 EPS of $0.02 beats by $0.05. Revenue of $126M (+19% Y/Y) beats by $8.5M....\" data-tweet=\"$SINA - Sina (NASDAQ:SINA): Q1 EPS of $0.02 beats by $0.05. Revenue of $126M (+19% Y/Y) beats by $8.5M. Expects Q2 revenue of $143M-$147M, above $142.7M consensus. Shares +4.6% AH. (PR) https://seekingalpha.com/news/1031071?source=tweet\" data-url=\"https://seekingalpha.com/news/1031071\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1031031\" data-ts=\"1368737333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1031031\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on J.C. Penney (NYSE:JCP) Q1 earnings: Cash burned through from operations is $752M vs....</a></h4><p>More on J.C. Penney (NYSE:<a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a>) Q1 <a href=\"https://seekingalpha.com/currents/post/1031001\" target=\"_blank\">earnings</a>: Cash burned through from operations is $752M vs. $577M a year ago. Cash used for capex of $214M vs. $107M a year ago. Totalled together, the company went through nearly $1B in cash in Q4 vs. $684M a year ago. New CEO Mike Ullman: \"We are looking forward, not back.\" Indeed. Shares are all over the place AH, currently flat. <a href=\"http://ir.jcpenney.com/\" target=\"_blank\">CC</a> at 5 ET. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1031031\" data-linked=\"More on J.C. Penney (NYSE:JCP) Q1 earnings: Cash burned through from operations is $752M vs....\" data-tweet=\"$JCP - More on J.C. Penney (NYSE:JCP) Q1 earnings: Cash burned through from operations is $752M vs. $577M a year ago. Cash used for capex of $214M vs. $107M a year ago. Totalled together, the company went through nearly $1B in cash in Q4 vs. $684M a yea... https://seekingalpha.com/news/1031031?source=tweet\" data-url=\"https://seekingalpha.com/news/1031031\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1031001\" data-ts=\"1368736576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1031001\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J. C. Penney (NYSE:JCP): Q1 EPS of -$1.31 misses by $0.35. Revenue of $2.64B misses by $0.08B....</a></h4><b>J. C. Penney (NYSE:<a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a>):</b> Q1 EPS of -$1.31 <font color=\"red\">misses by $0.35</font>. Revenue of $2.64B <font color=\"red\">misses by $0.08B</font>. Shares  <font color=\"green\">+1.4%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1031001\" data-linked=\"J. C. Penney (NYSE:JCP): Q1 EPS of -$1.31 misses by $0.35. Revenue of $2.64B misses by $0.08B....\" data-tweet=\"$JCP - J. C. Penney (NYSE:JCP): Q1 EPS of -$1.31 misses by $0.35. Revenue of $2.64B misses by $0.08B. Shares +1.4% AH. (PR) https://seekingalpha.com/news/1031001?source=tweet\" data-url=\"https://seekingalpha.com/news/1031001\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030941\" data-ts=\"1368735625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCLN\" target=\"_blank\">SCLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030941\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SciClone Pharmaceuticals (NASDAQ:SCLN) says it&#39;s entered into an agreement with Zensun Science...</a></h4><p>SciClone Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SCLN\" title=\"SciClone Pharmaceuticals, Inc.\">SCLN</a>) says it's entered into an agreement with Zensun Science &amp; Technology granting <a href=\"https://seekingalpha.com/symbol/SCLN\" title=\"SciClone Pharmaceuticals, Inc.\">SCLN</a> a license and exclusive marketing and distribution rights to sell Neucardin, a treatment for intermediate to advanced chronic heart failure, in China, Hong Kong and Macau.</p><div class=\"tiny-share-widget\" data-id=\"1030941\" data-linked=\"SciClone Pharmaceuticals (NASDAQ:SCLN) says it&#39;s entered into an agreement with Zensun Science...\" data-tweet=\"$SCLN - SciClone Pharmaceuticals (NASDAQ:SCLN) says it&#39;s entered into an agreement with Zensun Science &amp; Technology granting SCLN a license and exclusive marketing and distribution rights to sell Neucardin, a treatment for intermediate to advanced chron... https://seekingalpha.com/news/1030941?source=tweet\" data-url=\"https://seekingalpha.com/news/1030941\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030881\" data-ts=\"1368735229\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSRO\" target=\"_blank\">TSRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesaro (TSRO +14%) sets a new 52-week high today after the company said it will present data on...</a></h4><p>Tesaro (<a href=\"https://seekingalpha.com/symbol/TSRO\" title=\"Tesaro\">TSRO</a> <font color=\"green\">+14%</font>) sets a new 52-week high today after the company said it will present data on niraparib, its drug for ovarian and breast cancer, at the upcoming American Society of Clinical Oncology conference. The company says the data shows results from studies into 100 patients with solid tumors that confirms preliminary findings.</p><div class=\"tiny-share-widget\" data-id=\"1030881\" data-linked=\"Tesaro (TSRO +14%) sets a new 52-week high today after the company said it will present data on...\" data-tweet=\"$TSRO - Tesaro (TSRO +14%) sets a new 52-week high today after the company said it will present data on niraparib, its drug for ovarian and breast cancer, at the upcoming American Society of Clinical Oncology conference. The company says the data shows ... https://seekingalpha.com/news/1030881?source=tweet\" data-url=\"https://seekingalpha.com/news/1030881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030841\" data-ts=\"1368735028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRCD\" target=\"_blank\">BRCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030841\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brocade (NASDAQ:BRCD): FQ2 EPS of $0.17 beats by $0.02. Revenue of $538.8M misses by $5.44M....</a></h4><b>Brocade (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BRCD\" title=\"Brocade Communications Systems, Inc.\">BRCD</a>):</b> FQ2 EPS of $0.17 <font color=\"green\">beats by $0.02</font>. Revenue of $538.8M <font color=\"red\">misses by $5.44M</font>. Shares  <font color=\"red\">-5.9%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1030841\" data-linked=\"Brocade (NASDAQ:BRCD): FQ2 EPS of $0.17 beats by $0.02. Revenue of $538.8M misses by $5.44M....\" data-tweet=\"$BRCD - Brocade (NASDAQ:BRCD): FQ2 EPS of $0.17 beats by $0.02. Revenue of $538.8M misses by $5.44M. Shares -5.9% AH. (PR) https://seekingalpha.com/news/1030841?source=tweet\" data-url=\"https://seekingalpha.com/news/1030841\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030821\" data-ts=\"1368734846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordstrom (NYSE:JWN): Q1 EPS of $0.73 misses by $0.03. Revenue of $2.7B (+4.8% Y/Y) misses by...</a></h4><b>Nordstrom (NYSE:<a href=\"https://seekingalpha.com/symbol/JWN\" title=\"Nordstrom Inc.\">JWN</a>):</b> Q1 EPS of $0.73 <font color=\"red\">misses by $0.03</font>. Revenue of $2.7B (+4.8% Y/Y) <font color=\"red\">misses by $0.1B</font>. Shares  <font color=\"red\">-3.9%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1030821\" data-linked=\"Nordstrom (NYSE:JWN): Q1 EPS of $0.73 misses by $0.03. Revenue of $2.7B (+4.8% Y/Y) misses by...\" data-tweet=\"$JWN - Nordstrom (NYSE:JWN): Q1 EPS of $0.73 misses by $0.03. Revenue of $2.7B (+4.8% Y/Y) misses by $0.1B. Shares -3.9% AH. (PR) https://seekingalpha.com/news/1030821?source=tweet\" data-url=\"https://seekingalpha.com/news/1030821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030801\" data-ts=\"1368734785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARUN\" target=\"_blank\">ARUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030801\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aruba Networks (NASDAQ:ARUN): FQ3 EPS of $0.11 misses by $0.01. Revenue of $147.1M misses by...</a></h4><b>Aruba Networks (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARUN\" title=\"Aruba Networks, Inc.\">ARUN</a>):</b> FQ3 EPS of $0.11 <font color=\"red\">misses by $0.01</font>. Revenue of $147.1M <font color=\"red\">misses by $7.49M</font>. Shares  <font color=\"red\">-2.3%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1030801\" data-linked=\"Aruba Networks (NASDAQ:ARUN): FQ3 EPS of $0.11 misses by $0.01. Revenue of $147.1M misses by...\" data-tweet=\"$ARUN - Aruba Networks (NASDAQ:ARUN): FQ3 EPS of $0.11 misses by $0.01. Revenue of $147.1M misses by $7.49M. Shares -2.3% AH. (PR) https://seekingalpha.com/news/1030801?source=tweet\" data-url=\"https://seekingalpha.com/news/1030801\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030761\" data-ts=\"1368734602\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRS\" target=\"_blank\">TRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030761\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TriMas (TRS +1.3%) finishes higher after announcing earlier that it had promoted A. Mark Zeffiro...</a></h4><p>TriMas (<a href=\"https://seekingalpha.com/symbol/TRS\" title=\"TriMas Corporation\">TRS</a> <font color=\"green\">+1.3%</font>) finishes higher after announcing earlier that it had promoted A. Mark Zeffiro to executive vice president and chief financial officer. Zeffiro joined TRS June 2008 as acting CFO, with 25 years of financial, operational and business leadership experience with companies such as Black &amp; Decker and General Electric.</p><div class=\"tiny-share-widget\" data-id=\"1030761\" data-linked=\"TriMas (TRS +1.3%) finishes higher after announcing earlier that it had promoted A. Mark Zeffiro...\" data-tweet=\"$TRS - TriMas (TRS +1.3%) finishes higher after announcing earlier that it had promoted A. Mark Zeffiro to executive vice president and chief financial officer. Zeffiro joined TRS June 2008 as acting CFO, with 25 years of financial, operational and busi... https://seekingalpha.com/news/1030761?source=tweet\" data-url=\"https://seekingalpha.com/news/1030761\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030691\" data-ts=\"1368734110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANAD\" target=\"_blank\">ANAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030691\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anadigics (ANAD +5.1%) is closing sharply higher after announcing 3 of its power amplifiers and...</a></h4><p>Anadigics (<a href=\"https://seekingalpha.com/symbol/ANAD\" title=\"ANADIGICS, Inc.\">ANAD</a> <font color=\"green\">+5.1%</font>) is closing sharply higher after announcing 3 of its power amplifiers and a front-end IC (FEIC) for the next-gen 802.11ac Wi-Fi standard are used in versions of Samsung's Galaxy S4. The announcement comes 2 weeks after Anadigics stated its Wi-Fi FEIC sales <a href=\"https://seekingalpha.com/currents/post/982291\" target=\"_blank\">grew over 4x Q/Q in Q1</a> to $4.8M, and made up 18% of revenue. Wi-Fi chipset reference design wins with market leader Broadcom and others have given the business a lift. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1030691\" data-linked=\"Anadigics (ANAD +5.1%) is closing sharply higher after announcing 3 of its power amplifiers and...\" data-tweet=\"$ANAD - Anadigics (ANAD +5.1%) is closing sharply higher after announcing 3 of its power amplifiers and a front-end IC (FEIC) for the next-gen 802.11ac Wi-Fi standard are used in versions of Samsung&#39;s Galaxy S4. The announcement comes 2 weeks after Anad... https://seekingalpha.com/news/1030691?source=tweet\" data-url=\"https://seekingalpha.com/news/1030691\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030631\" data-ts=\"1368733092\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLBS\" target=\"_blank\">CLBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030631\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NeoStem (NBS +1.5%) holds in the green today after the company announced the geographic patent...</a></h4><p>NeoStem (NBS <font color=\"green\">+1.5%</font>) holds in the green today after the company announced the geographic patent expansion of its lead product candidate, AMR-001, with the notice of a grant in Malaysia and notice of recommendation for allowance in the Philippines. These patents are in the family of US patent titled \"Compositions and Methods of Vascular Injury Repair\" and protected a chemotactic stem cell product enriched for CD34+ cells that treats injury from acute myocardial infarction.</p><div class=\"tiny-share-widget\" data-id=\"1030631\" data-linked=\"NeoStem (NBS +1.5%) holds in the green today after the company announced the geographic patent...\" data-tweet=\"$CLBS - NeoStem (NBS +1.5%) holds in the green today after the company announced the geographic patent expansion of its lead product candidate, AMR-001, with the notice of a grant in Malaysia and notice of recommendation for allowance in the Philippines... https://seekingalpha.com/news/1030631?source=tweet\" data-url=\"https://seekingalpha.com/news/1030631\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030581\" data-ts=\"1368732198\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLNK\" target=\"_blank\">NLNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030581\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NewLink Genetics (NLNK +2.1%) moves up after being selected for addition to the NASDAQ...</a></h4><p>NewLink Genetics (<a href=\"https://seekingalpha.com/symbol/NLNK\" title=\"NewLink Genetics Corporation\">NLNK</a> <font color=\"green\">+2.1%</font>) moves up after being selected for addition to the NASDAQ Biotechnology Index, effective prior to the market open on Monday.</p><div class=\"tiny-share-widget\" data-id=\"1030581\" data-linked=\"NewLink Genetics (NLNK +2.1%) moves up after being selected for addition to the NASDAQ...\" data-tweet=\"$NLNK - NewLink Genetics (NLNK +2.1%) moves up after being selected for addition to the NASDAQ Biotechnology Index, effective prior to the market open on Monday. https://seekingalpha.com/news/1030581?source=tweet\" data-url=\"https://seekingalpha.com/news/1030581\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030551\" data-ts=\"1368731695\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVLN\" target=\"_blank\">NVLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030551\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aegerion Pharmaceuticals (AEGR +32%) goes on a tear today, after CEO Marc Beer painted an upbeat...</a></h4><p>Aegerion Pharmaceuticals (AEGR <font color=\"green\">+32%</font>) goes on a tear today, after CEO Marc Beer painted an upbeat picture for its rare-cholesterol-disease drug Juxtapid at a conference late yesterday. According to slides, Juxtapid will cost about $235K at initiation and will increase to $295K as of June 1st. Maintenance-stage costs will be around $295K, which will likely prompt the Street to adjust forecasts higher. View webcast here: (<a href=\"http://ir.aegerion.com/eventdetail.cfm?EventID=130027\" target=\"_blank\">Aegerion Presentation</a>)</p><div class=\"tiny-share-widget\" data-id=\"1030551\" data-linked=\"Aegerion Pharmaceuticals (AEGR +32%) goes on a tear today, after CEO Marc Beer painted an upbeat...\" data-tweet=\"$NVLN $NVLNF - Aegerion Pharmaceuticals (AEGR +32%) goes on a tear today, after CEO Marc Beer painted an upbeat picture for its rare-cholesterol-disease drug Juxtapid at a conference late yesterday. According to slides, Juxtapid will cost about $235K at... https://seekingalpha.com/news/1030551?source=tweet\" data-url=\"https://seekingalpha.com/news/1030551\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030521\" data-ts=\"1368731407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOL\" target=\"_blank\">SOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030521\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ReneSola&#39;s (SOL -14%) larger than expected Q1 loss on falling prices and shipments has shares...</a></h4><p>ReneSola's (<a href=\"https://seekingalpha.com/symbol/SOL\" title=\"ReneSola Ltd.\">SOL</a> <font color=\"red\">-14%</font>) larger than expected <a href=\"https://seekingalpha.com/currents/post/1029041\" target=\"_blank\">Q1 loss</a> on falling prices and shipments has <a href=\"http://blogs.barrons.com/emergingmarketsdaily/2013/05/16/renesola-plunges-13-drags-china-solar-stocks-down-with-it\" target=\"_blank\">shares reeling</a> and is dragging down other Chinese solar stocks. SOL offered an optimistic take on the rest of the year, saying Q2 sales could hit $330M, but investors aren't impressed. <a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a> <font color=\"red\">-4.2%</font>, <a href=\"https://seekingalpha.com/symbol/JASO\" title=\"JA Solar Holdings, Co., Ltd.\">JASO</a> <font color=\"red\">-3.5%</font>, <a href=\"https://seekingalpha.com/symbol/STP\" title=\"Suntech Power Holdings Co., Ltd.\">STP</a> <font color=\"red\">-1%</font>, but <a href=\"https://seekingalpha.com/symbol/YGE\" title=\"Yingli Green Energy Holding Company Limited\">YGE</a> <font color=\"green\">+2%</font>.</p><div class=\"tiny-share-widget\" data-id=\"1030521\" data-linked=\"ReneSola&#39;s (SOL -14%) larger than expected Q1 loss on falling prices and shipments has shares...\" data-tweet=\"$SOL $SOL $TSL - ReneSola&#39;s (SOL -14%) larger than expected Q1 loss on falling prices and shipments has shares reeling and is dragging down other Chinese solar stocks. SOL offered an optimistic take on the rest of the year, saying Q2 sales could hit $33... https://seekingalpha.com/news/1030521?source=tweet\" data-url=\"https://seekingalpha.com/news/1030521\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030501\" data-ts=\"1368731040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEMI\" target=\"_blank\">CEMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030501\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chembio Diagnostics (CEMI -1.3%) says it&#39;s entered into a six-month follow-on, milestone-based...</a></h4><p>Chembio Diagnostics (<a href=\"https://seekingalpha.com/symbol/CEMI\" title=\"Chembio Diagnostics, Inc.\">CEMI</a> <font color=\"red\">-1.3%</font>) says it's entered into a six-month follow-on, milestone-based development agreement with a private contracting organization to implement and provide technical oversight relating to pandemic preparedness on behalf of the US Centers for Disease Control and Prevention, for a rapid, POC influenza immunity test utilizing <a href=\"https://seekingalpha.com/symbol/CEMI\" title=\"Chembio Diagnostics, Inc.\">CEMI</a>'s patented Dual Path Platform technology.</p><div class=\"tiny-share-widget\" data-id=\"1030501\" data-linked=\"Chembio Diagnostics (CEMI -1.3%) says it&#39;s entered into a six-month follow-on, milestone-based...\" data-tweet=\"$CEMI - Chembio Diagnostics (CEMI -1.3%) says it&#39;s entered into a six-month follow-on, milestone-based development agreement with a private contracting organization to implement and provide technical oversight relating to pandemic preparedness on behalf... https://seekingalpha.com/news/1030501?source=tweet\" data-url=\"https://seekingalpha.com/news/1030501\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030471\" data-ts=\"1368730685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADES\" target=\"_blank\">ADES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030471\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Red-hot ADA-ES (ADES +6.4%) gets even hotter as new SA author Nick Toor says it&#39;s a matter of...</a></h4>Red-hot ADA-ES (<a href='https://seekingalpha.com/symbol/ADES' title='Advanced Emissions Solutions, Inc.'>ADES</a> <font color='green'>+6.4%</font>) gets even hotter as new SA author Nick Toor says it's a <a href=\"https://seekingalpha.com/article/1439071-ada-es-turning-coal-into-cash\" target=\"_blank\">matter of when</a>, not if, the company's refined coal operation (a JV with Goldman Sachs as minority partner) is able to monetize its tax assets. Assigning zero value to the rest of the company, Toor believes there's another 70% of upside over the next 12 months.<div class=\"tiny-share-widget\" data-id=\"1030471\" data-linked=\"Red-hot ADA-ES (ADES +6.4%) gets even hotter as new SA author Nick Toor says it&#39;s a matter of...\" data-tweet=\"$ADES - Red-hot ADA-ES (ADES +6.4%) gets even hotter as new SA author Nick Toor says it&#39;s a matter of when, not if, the company&#39;s refined coal operation (a JV with Goldman Sachs as minority partner) is able to monetize its tax assets. Assigning zero val... https://seekingalpha.com/news/1030471?source=tweet\" data-url=\"https://seekingalpha.com/news/1030471\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030381\" data-ts=\"1368729911\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRPN\" target=\"_blank\">GRPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030381\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Groupon (GRPN +4%) can eventually produce $100B/year in sales, co-CEO Ted Leonsis insists; the...</a></h4><p>Groupon (<a href=\"https://seekingalpha.com/symbol/GRPN\" title=\"Groupon, Inc.\">GRPN</a> <font color=\"green\">+4%</font>) can eventually <a href=\"http://www.businessinsider.com/groupon-we-can-be-a-100-billion-company-2013-5\" target=\"_blank\">produce $100B/year in sales</a>, co-CEO Ted Leonsis insists; the remark could be giving a lift to shares, as tough as it may be to buy into. For reference, Groupon's 2013 <a href=\"http://finance.yahoo.com/q/ae?s=GRPN+Analyst+Estimates\" target=\"_blank\">consensus revenue forecast</a> is $2.5B, and Amazon's consensus is $74.8B. <a href=\"https://seekingalpha.com/currents/post/417341\" target=\"_blank\">Much like</a> the departed Andrew Mason, Groupon's leadership sees the company reaching such lofty heights by developing into a soup-to-nuts local commerce services provider for merchants (with a strong mobile component), and expanding into many new product/services categories.</p><div class=\"tiny-share-widget\" data-id=\"1030381\" data-linked=\"Groupon (GRPN +4%) can eventually produce $100B/year in sales, co-CEO Ted Leonsis insists; the...\" data-tweet=\"$GRPN - Groupon (GRPN +4%) can eventually produce $100B/year in sales, co-CEO Ted Leonsis insists; the remark could be giving a lift to shares, as tough as it may be to buy into. For reference, Groupon&#39;s 2013 consensus revenue forecast is $2.5B, and Ama... https://seekingalpha.com/news/1030381?source=tweet\" data-url=\"https://seekingalpha.com/news/1030381\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030331\" data-ts=\"1368729021\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTP\" target=\"_blank\">MTP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030331\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dara Biosciences (DARA -3%) slips after its Q1 EPS missed estimates yesterday. Bottom line...</a></h4><p>Dara Biosciences (DARA <font color=\"red\">-3%</font>) slips after its <a href=\"https://seekingalpha.com/market_currents/post/1028191\" target=\"_blank\">Q1 EPS missed estimates</a> yesterday. Bottom line results were negatively impacted by costs incurred in the establishment of a sales and marketing, distribution and regulatory infrastructure to support the promotion of its oncology and oncology supportive care products.</p><div class=\"tiny-share-widget\" data-id=\"1030331\" data-linked=\"Dara Biosciences (DARA -3%) slips after its Q1 EPS missed estimates yesterday. Bottom line...\" data-tweet=\"$MTP - Dara Biosciences (DARA -3%) slips after its Q1 EPS missed estimates yesterday. Bottom line results were negatively impacted by costs incurred in the establishment of a sales and marketing, distribution and regulatory infrastructure to support the... https://seekingalpha.com/news/1030331?source=tweet\" data-url=\"https://seekingalpha.com/news/1030331\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030321\" data-ts=\"1368728960\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HES\" target=\"_blank\">HES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030321\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Even if the entertainment of a good brawl was denied, Hess (HES -2.3%) shareholders should savor...</a></h4>Even if the entertainment of a good brawl was <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1029311\">denied</a>, Hess (<a href='https://seekingalpha.com/symbol/HES' title='Hess Corporation'>HES</a> <font color=\"red\">-2.3%</font>) shareholders should savor the <a target=\"_blank\" href=\"http://blogs.wsj.com/moneybeat/2013/05/16/hesss-peace-dividend/\">potential for further gains</a>, Liam Denning writes. Hess has diluted its namesake CEO&rsquo;s influence by taking the chairmanship away from him, revamped a fossilizing board, raised the dividend for the first time in years, and moved to streamline the company. Plus, it's now a <a href=\"https://seekingalpha.com/currents/post/906781\" target=\"_blank\">more realistic takeover target</a>.<div class=\"tiny-share-widget\" data-id=\"1030321\" data-linked=\"Even if the entertainment of a good brawl was denied, Hess (HES -2.3%) shareholders should savor...\" data-tweet=\"$HES - Even if the entertainment of a good brawl was denied, Hess (HES -2.3%) shareholders should savor the potential for further gains, Liam Denning writes. Hess has diluted its namesake CEO&amp;rsquo;s influence by taking the chairmanship away from him, r... https://seekingalpha.com/news/1030321?source=tweet\" data-url=\"https://seekingalpha.com/news/1030321\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030301\" data-ts=\"1368728207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTX\" target=\"_blank\">PTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030301\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Pernix Therapeutics (PTX -5.6%) hits a new 52-week low today, continuing its downtrend...</a></h4><p>Shares of Pernix Therapeutics (<a href=\"https://seekingalpha.com/symbol/PTX\" title=\"Pernix Therapeutics Holdings, Inc.\">PTX</a> <font color=\"red\">-5.6%</font>) hits a new 52-week low today, continuing its downtrend following a disappointing <a href=\"https://seekingalpha.com/market_currents/post/1018101\" target=\"_blank\">Q1 report</a> last week. Additionally, Cantor <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/05/3591226/update-cantor-fitzgerald-lowers-pt-on-pernix-therapeutic\" target=\"_blank\">cut its price target</a> on the stock to $3 from $7, citing concerns that the company could take a year or so to stabilize following the appointment of new CEO Mike Pearce.</p><div class=\"tiny-share-widget\" data-id=\"1030301\" data-linked=\"Shares of Pernix Therapeutics (PTX -5.6%) hits a new 52-week low today, continuing its downtrend...\" data-tweet=\"$PTX $PTX-OLD - Shares of Pernix Therapeutics (PTX -5.6%) hits a new 52-week low today, continuing its downtrend following a disappointing Q1 report last week. Additionally, Cantor cut its price target on the stock to $3 from $7, citing concerns that th... https://seekingalpha.com/news/1030301?source=tweet\" data-url=\"https://seekingalpha.com/news/1030301\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030241\" data-ts=\"1368726591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNVR\" target=\"_blank\">CNVR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030241\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ValueClick (VCLK -2.3%) slumps after Northland starts coverage with an Underperform and $21 PT....</a></h4><p>ValueClick (VCLK <font color=\"red\">-2.3%</font>) slumps after <a target=\"_blank\" href=\"https://twitter.com/MarketEdgeLive/status/335017932855844865\">Northland starts coverage</a> with an Underperform and $21 PT. Shares are down 17% since the online ad services/tech provider posted <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1006151\">mixed Q1 results</a> and <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1006531\">offered light guidance</a> on May 7, but remain up 36% YTD.</p><div class=\"tiny-share-widget\" data-id=\"1030241\" data-linked=\"ValueClick (VCLK -2.3%) slumps after Northland starts coverage with an Underperform and $21 PT....\" data-tweet=\"$CNVR - ValueClick (VCLK -2.3%) slumps after Northland starts coverage with an Underperform and $21 PT. Shares are down 17% since the online ad services/tech provider posted mixed Q1 results and offered light guidance on May 7, but remain up 36% YTD. https://seekingalpha.com/news/1030241?source=tweet\" data-url=\"https://seekingalpha.com/news/1030241\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030231\" data-ts=\"1368726549\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REGN\" target=\"_blank\">REGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030231\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biotech names are weak today on the back of several ASCO data presentation releases: REGN -2.3%,...</a></h4><p>Biotech names are weak today on the back of several ASCO data presentation releases: <a href=\"https://seekingalpha.com/symbol/REGN\" title=\"Regeneron Pharmaceuticals, Inc.\">REGN</a> <font color=\"red\">-2.3%</font>, <a href=\"https://seekingalpha.com/symbol/ALXN\" title=\"Alexion Pharmaceuticals, Inc.\">ALXN</a> <font color=\"red\">-4.2%</font>, <a href=\"https://seekingalpha.com/symbol/VRTX\" title=\"Vertex Pharmaceuticals Incorporated\">VRTX</a> <font color=\"red\">-2.3%</font>, <a href=\"https://seekingalpha.com/symbol/CELG\" title=\"Celgene Corporation\">CELG</a> <font color=\"red\">-4.5%</font>, <a href=\"https://seekingalpha.com/symbol/ARRY\" title=\"Array BioPharma Inc.\">ARRY</a> <font color=\"red\">-2.2%</font>, <a href=\"https://seekingalpha.com/symbol/AMGN\" title=\"Amgen Inc.\">AMGN</a> <font color=\"red\">-1.4%</font>.</p><div class=\"tiny-share-widget\" data-id=\"1030231\" data-linked=\"Biotech names are weak today on the back of several ASCO data presentation releases: REGN -2.3%,...\" data-tweet=\"$REGN $REGN $ALXN - Biotech names are weak today on the back of several ASCO data presentation releases: REGN -2.3%, ALXN -4.2%, VRTX -2.3%, CELG -4.5%, ARRY -2.2%, AMGN -1.4%. https://seekingalpha.com/news/1030231?source=tweet\" data-url=\"https://seekingalpha.com/news/1030231\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030221\" data-ts=\"1368725973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFI\" target=\"_blank\">INFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030221\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinity Pharmaceuticals (INFI -20.5%) gets slammed by cautious comments out of JPMorgan today,...</a></h4><p>Infinity Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/INFI\" title=\"Infinity Pharmaceuticals, Inc.\">INFI</a> <font color=\"red\">-20.5%</font>) gets slammed by <a href=\"http://online.wsj.com/article/BT-CO-20130516-708316.html?mod=googlenews_wsj\" target=\"_blank\">cautious comments</a> out of JPMorgan today, saying that investors are \"growing increasingly skittish\" ahead of <a href=\"https://seekingalpha.com/symbol/INFI\" title=\"Infinity Pharmaceuticals, Inc.\">INFI</a>'s pending presentation at June's ASCO cancer conference. The company is expected to release Phase 1 clinical safety and tolerability data for IPI-145, its experimental leukemia drug, and while the investment bank predicts \"a good showing,\" it may not be enough to outshine Gilead (<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a> <font color=\"red\">-2.3%</font>), Pharmacyclics (<a href=\"https://seekingalpha.com/symbol/PCYC\" title=\"Pharmacyclics, Inc.\">PCYC</a> <font color=\"red\">-2.5%</font>) or Roche (<a href=\"https://seekingalpha.com/symbol/RHHBY\" title=\"Roche Holding Ltd ADR\">OTCQX:RHHBY</a> <font color=\"red\">-0.6%</font>).</p><div class=\"tiny-share-widget\" data-id=\"1030221\" data-linked=\"Infinity Pharmaceuticals (INFI -20.5%) gets slammed by cautious comments out of JPMorgan today,...\" data-tweet=\"$INFI $INFI $GILD - Infinity Pharmaceuticals (INFI -20.5%) gets slammed by cautious comments out of JPMorgan today, saying that investors are &quot;growing increasingly skittish&quot; ahead of INFI&#39;s pending presentation at June&#39;s ASCO cancer conference. The comp... https://seekingalpha.com/news/1030221?source=tweet\" data-url=\"https://seekingalpha.com/news/1030221\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030211\" data-ts=\"1368725968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXC\" target=\"_blank\">DXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030211\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Computer Sciences (CSC -4.4%) adds to yesterday&#39;s post-earnings losses after Deutsche cuts...</a></h4>Computer Sciences (CSC <font color='red'>-4.4%</font>) adds to yesterday's <a href=\"https://seekingalpha.com/currents/post/1027581\" target=\"_blank\">post-earnings losses</a> after Deutsche <a href=\"http://www.streetinsider.com/Downgrades/Deutsche+Bank+Downgrades+Computer+Sciences+%28CSC%29+to+Hold/8345575.html\" target=\"_blank\">cuts shares to Hold</a>. With CSC forecasting an FY14 cost takeout of $400M (above Deutsche's estimate of $300M) and investments of $300M (above an estimate of $250M), the firm sees \"less room for error and fewer margin expansion opportunities.\" Separately, CSC has <a href=\"http://www.reuters.com/article/2013/05/16/computersciences-settlement-idUSL2N0DX0RX20130516?feedType=RSS&amp;feedName=industrialsSector&amp;rpc=43\" target=\"_blank\">settled a shareholder lawsuit</a> over its <a href=\"https://seekingalpha.com/currents/post/67526\" target=\"_blank\">accounting woes</a> for $97.5M. Shares now <font color=\"red\">-14%</font> from Tuesday's close. (<a href=\"https://seekingalpha.com/article/1437381-computer-sciences-management-discusses-q4-2013-results-earnings-call-transcript\" target=\"_blank\">CC transcript</a>)<div class=\"tiny-share-widget\" data-id=\"1030211\" data-linked=\"Computer Sciences (CSC -4.4%) adds to yesterday&#39;s post-earnings losses after Deutsche cuts...\" data-tweet=\"$DXC - Computer Sciences (CSC -4.4%) adds to yesterday&#39;s post-earnings losses after Deutsche cuts shares to Hold. With CSC forecasting an FY14 cost takeout of $400M (above Deutsche&#39;s estimate of $300M) and investments of $300M (above an estimate of $250... https://seekingalpha.com/news/1030211?source=tweet\" data-url=\"https://seekingalpha.com/news/1030211\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030201\" data-ts=\"1368725455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBSAA\" target=\"_blank\">SBSAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030201\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spanish Broadcasting System (SBSA): Q1 EPS of -$0.72 (-$0.85 in Q1 2012). Revenue of $39.103M...</a></h4><b>Spanish Broadcasting System (SBSA):</b> Q1 EPS of -$0.72 (-$0.85 in Q1 2012). Revenue of $39.103M (<font color=\"green\">+22%</font> Y/Y). Shares <font color=\"green\">+31%</font>. The company also says its New York station has achieved \"significant ratings gains\" and \"strengthened its market position.\"(PR)<div class=\"tiny-share-widget\" data-id=\"1030201\" data-linked=\"Spanish Broadcasting System (SBSA): Q1 EPS of -$0.72 (-$0.85 in Q1 2012). Revenue of $39.103M...\" data-tweet=\"$SBSAA - Spanish Broadcasting System (SBSA): Q1 EPS of -$0.72 (-$0.85 in Q1 2012). Revenue of $39.103M (+22% Y/Y). Shares +31%. The company also says its New York station has achieved &quot;significant ratings gains&quot; and &quot;strengthened its market position.&quot;(PR) https://seekingalpha.com/news/1030201?source=tweet\" data-url=\"https://seekingalpha.com/news/1030201\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030181\" data-ts=\"1368725351\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARIA\" target=\"_blank\">ARIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030181\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ariad&#39;s (ARIA -4.5%) slides on reports that a growing number of tools are allowing many cancer...</a></h4><p>Ariad's (<a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"red\">-4.5%</font>) slides on reports that a growing number of tools are allowing many cancer patients to <a href=\"http://www.foxnews.com/health/2013/05/16/new-cancer-tools-allow-patients-to-reconsider-chemo/\" target=\"_blank\">skip chemotherapy</a> or other cancer treatments. Also, ongoing trials of its experimental cancer drug AP26113 has only clouded the picture regarding its potential. A smaller proportion of patients saw their tumors shrink than shown in a previous release and it's unclear whether 2 patient deaths were caused by the drug or something else. Analysts expect more clarity when <a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> presents more-mature data at June's ASCO cancer meeting.</p><div class=\"tiny-share-widget\" data-id=\"1030181\" data-linked=\"Ariad&#39;s (ARIA -4.5%) slides on reports that a growing number of tools are allowing many cancer...\" data-tweet=\"$ARIA - Ariad&#39;s (ARIA -4.5%) slides on reports that a growing number of tools are allowing many cancer patients to skip chemotherapy or other cancer treatments. Also, ongoing trials of its experimental cancer drug AP26113 has only clouded the picture re... https://seekingalpha.com/news/1030181?source=tweet\" data-url=\"https://seekingalpha.com/news/1030181\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030141\" data-ts=\"1368723618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBGGY\" target=\"_blank\">NBGGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030141\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">National Bank of Greece (NBG +23.7%) continues to fly, with the latest catalyst an upgrade of...</a></h4><p>National Bank of Greece (NBG <font color=\"green\">+23.7%</font>) continues to fly, with the latest catalyst <a href=\"http://www.fitchratings.com/creditdesk/press_releases/detail.cfm?pr_id=791322\" target=\"_blank\">an upgrade of the country's banking sector</a> by Fitch - the big lenders moved to B- from CCC. The move follows<a href=\"https://seekingalpha.com/currents/post/1024091\" target=\"_blank\"> Fitch's upgrade</a> of the sovereign to B- earlier this week and the bank's apparent success in raising private capital, thus avoiding nationalization. NBG has tripled in value in the last month. Nothing to see here, move along. <a href=\"https://seekingalpha.com/symbol/GREK\" title=\"Global X MSCI Greece ETF\">GREK</a><font color=\"green\"> +3.1%</font>.</p><div class=\"tiny-share-widget\" data-id=\"1030141\" data-linked=\"National Bank of Greece (NBG +23.7%) continues to fly, with the latest catalyst an upgrade of...\" data-tweet=\"$NBGGY $NBGGY $GREK - National Bank of Greece (NBG +23.7%) continues to fly, with the latest catalyst an upgrade of the country&#39;s banking sector by Fitch - the big lenders moved to B- from CCC. The move follows Fitch&#39;s upgrade of the sovereign to B- ear... https://seekingalpha.com/news/1030141?source=tweet\" data-url=\"https://seekingalpha.com/news/1030141\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030121\" data-ts=\"1368723325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASC\" target=\"_blank\">CASC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030121\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oncothyreon (ONTY -20.7%) tanks today after presenting data as ASCO that showed Phase III trials...</a></h4><p>Oncothyreon (ONTY <font color=\"red\">-20.7%</font>) tanks today after presenting data as ASCO that showed Phase III trials of its investigational MUC1 antigen-specific cancer immunotherapy L-BLP25 didn't meet its primary objective. The trial was conducted by Merck Serono, a division of Merck (<a href=\"https://seekingalpha.com/symbol/MRK\" title=\"Merck &amp; Co Inc.\">MRK</a> <font color=\"red\">-0.7%</font>), under a license agreement with ONTY.</p><div class=\"tiny-share-widget\" data-id=\"1030121\" data-linked=\"Oncothyreon (ONTY -20.7%) tanks today after presenting data as ASCO that showed Phase III trials...\" data-tweet=\"$CASC $CASC $MRK - Oncothyreon (ONTY -20.7%) tanks today after presenting data as ASCO that showed Phase III trials of its investigational MUC1 antigen-specific cancer immunotherapy L-BLP25 didn&#39;t meet its primary objective. The trial was conducted by M... https://seekingalpha.com/news/1030121?source=tweet\" data-url=\"https://seekingalpha.com/news/1030121\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030101\" data-ts=\"1368723074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGLE\" target=\"_blank\">EGLE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: EGLE +46%. NBG +24%. SBSA +23%. DQ +22%. GNK +19%. AEGR +19%. GLBS +17%....</a></h4><b>Midday top 10 gainers:</b> <a href=\"https://seekingalpha.com/symbol/EGLE\" title=\"Eagle Bulk Shipping Inc.\">EGLE</a> <font color=\"green\">+46%</font>. NBG <font color=\"green\">+24%</font>. SBSA <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/DQ\" title=\"DAQO New Energy Corp.\">DQ</a> <font color=\"green\">+22%</font>. <a href=\"https://seekingalpha.com/symbol/GNK\" title=\"Genco Shipping &amp; Trading Ltd.\">GNK</a> <font color=\"green\">+19%</font>. AEGR <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/GLBS\" title=\"Globus Maritime Ltd.\">GLBS</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/SINO\" title=\"Sino-Global Shipping America, Ltd.\">SINO</a> <font color=\"green\">+17%</font>. PRGN <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/LWAY\" title=\"Lifeway Foods, Inc.\">LWAY</a> <font color=\"green\">+16%</font>.<br> <b>Midday top 10 losers:</b> NCT <font color=\"red\">-54%</font>. <a href=\"https://seekingalpha.com/symbol/SNFCA\" title=\"Security National Financial Corporation\">SNFCA</a> <font color=\"red\">-22%</font>. ONTY <font color=\"red\">-21%</font>. <a href=\"https://seekingalpha.com/symbol/INFI\" title=\"Infinity Pharmaceuticals, Inc.\">INFI</a> <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/CNIT-OLD\" title=\"China Information Technology\">CNIT-OLD</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/CYCC\" title=\"Cyclacel Pharmaceuticals, Inc.\">CYCC</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/PTSX\" title=\"Point.360\">OTC:PTSX</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/AMD\" title=\"Advanced Micro Devices, Inc.\">AMD</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/BDCO\" title=\"Blue Dolphin Energy Co.\">OTCQX:BDCO</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/TRIT\" title=\"Tri-Tech Holding, Inc.\">TRIT</a> <font color=\"red\">-11%</font>.<div class=\"tiny-share-widget\" data-id=\"1030101\" data-linked=\"Midday top 10 gainers: EGLE +46%. NBG +24%. SBSA +23%. DQ +22%. GNK +19%. AEGR +19%. GLBS +17%....\" data-tweet=\"$EGLE $EGLE $NBGGY - Midday top 10 gainers: EGLE +46%. NBG +24%. SBSA +23%. DQ +22%. GNK +19%. AEGR +19%. GLBS +17%. SINO +17%. PRGN +16%. LWAY +16%. Midday top 10 losers: NCT -54%. SNFCA -22%. ONTY -21%. INFI -19%. CNIT-OLD -15%. CYCC -14%. OTC:PTSX -1... https://seekingalpha.com/news/1030101?source=tweet\" data-url=\"https://seekingalpha.com/news/1030101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030081\" data-ts=\"1368722725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030081\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivus (VVUS -3.3%) slips today after pricing its $220M private placement of convertible senior...</a></h4><p>Vivus (<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"red\">-3.3%</font>) slips today after pricing its $220M private placement of convertible senior unsecured notes due May 1, 2020. The notes will bear interest at a fixed annual rate of 4.50%, payable semiannually in arrears on May 1 and November 1 of each year, beginning on November 1, 2013. The net proceeds from the offering are expected to be approximately $213M.</p><div class=\"tiny-share-widget\" data-id=\"1030081\" data-linked=\"Vivus (VVUS -3.3%) slips today after pricing its $220M private placement of convertible senior...\" data-tweet=\"$VVUS - Vivus (VVUS -3.3%) slips today after pricing its $220M private placement of convertible senior unsecured notes due May 1, 2020. The notes will bear interest at a fixed annual rate of 4.50%, payable semiannually in arrears on May 1 and November 1... https://seekingalpha.com/news/1030081?source=tweet\" data-url=\"https://seekingalpha.com/news/1030081\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030071\" data-ts=\"1368722580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMC\" target=\"_blank\">WMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030071\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">It&#39;s a nice bounce for the mortgage REITs (MORT +1.3%) today as a string of weak economic data...</a></h4>It's a nice bounce for the mortgage REITs (<a href='https://seekingalpha.com/symbol/MORT' title='VanEck Vectors Mortgage REIT Income ETF'>MORT</a> <font color=\"green\">+1.3%</font>) today as a string of weak economic data leads to a big drop in Treasury yields, the 10-year off 6 bps to 1.88%. Leading gains is Western Asset Mortgage (<a href='https://seekingalpha.com/symbol/WMC' title='Western Asset Mortgage Capital Corporation'>WMC</a> <font color=\"green\">+3.3%</font>) following yesterday's 8% <a href=\"https://seekingalpha.com/currents/post/1026511\" target=\"_blank\">post-earnings</a> drubbing. CEO Jim Gavin took advantage, adding 12.8% to his stake by <a href=\"http://investorrelations.westernassetmcc.com/ShowFile.aspx?KeyFile=17028743&amp;Format=XML&amp;Output=XML\" target=\"_blank\">buying about $42K</a> worth of stock at $19.96 each. Other movers include: (<a href='https://seekingalpha.com/symbol/CMO' title='Capstead Mortgage Corporation'>CMO</a> <font color=\"green\">+2.1%</font>), (<a href='https://seekingalpha.com/symbol/NLY' title='Annaly Capital Management, Inc.'>NLY</a> <font color=\"green\">+1.9%</font>), (<a href='https://seekingalpha.com/symbol/ARR' title='ARMOUR Residential REIT, Inc.'>ARR</a> <font color=\"green\">+2.6%</font>), (<a href='https://seekingalpha.com/symbol/IVR' title='Invesco Mortgage Capital Inc.'>IVR</a> <font color=\"green\">+1.8%</font>).<div class=\"tiny-share-widget\" data-id=\"1030071\" data-linked=\"It&#39;s a nice bounce for the mortgage REITs (MORT +1.3%) today as a string of weak economic data...\" data-tweet=\"$WMC $MORT $WMC - It&#39;s a nice bounce for the mortgage REITs (MORT +1.3%) today as a string of weak economic data leads to a big drop in Treasury yields, the 10-year off 6 bps to 1.88%. Leading gains is Western Asset Mortgage (WMC +3.3%) following yester... https://seekingalpha.com/news/1030071?source=tweet\" data-url=\"https://seekingalpha.com/news/1030071\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030051\" data-ts=\"1368722032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DSCI\" target=\"_blank\">DSCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030051\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Derma Sciences (DSCI -2.7%) slips after reporting a narrower Q1 loss versus the Street, but...</a></h4><p>Derma Sciences (<a href=\"https://seekingalpha.com/symbol/DSCI\" title=\"Derma Sciences Inc.\">DSCI</a> <font color=\"red\">-2.7%</font>) slips after reporting a narrower <a href=\"https://seekingalpha.com/market_currents/post/1029051\" target=\"_blank\">Q1 loss</a> versus the Street, but revenue comes up short as traditional wound care product sales suffered from seasonality. Advanced wound care products rose 67% over the prior year however - accounting for 40% of net sales - compared with 29% Q112. Gross margin rose to 35.7% from 31.9%.</p><div class=\"tiny-share-widget\" data-id=\"1030051\" data-linked=\"Derma Sciences (DSCI -2.7%) slips after reporting a narrower Q1 loss versus the Street, but...\" data-tweet=\"$DSCI - Derma Sciences (DSCI -2.7%) slips after reporting a narrower Q1 loss versus the Street, but revenue comes up short as traditional wound care product sales suffered from seasonality. Advanced wound care products rose 67% over the prior year howev... https://seekingalpha.com/news/1030051?source=tweet\" data-url=\"https://seekingalpha.com/news/1030051\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030041\" data-ts=\"1368722030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FANG\" target=\"_blank\">FANG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030041\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diamondback Energy (FANG +3.2%) is raised to Buy from Hold with a $35 target price (from $25) at...</a></h4><p>Diamondback Energy (<a href=\"https://seekingalpha.com/symbol/FANG\" title=\"Diamondback Energy\">FANG</a> <font color=\"green\">+3.2%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/05/3596464/update-wunderlich-upgrades-diamondback-energy-to-buy-on-\" target=\"_blank\">raised to Buy</a> from Hold with a $35 target price (from $25) at Wunderlich, which believes strong results from 13 Wolfcamp B-targeted horizontal wells (11 operated) shows the operational expertise, asset strength and horizontal potential for FANG, while the recent equity offering puts it in a position to fund and accelerate its growth.</p><div class=\"tiny-share-widget\" data-id=\"1030041\" data-linked=\"Diamondback Energy (FANG +3.2%) is raised to Buy from Hold with a $35 target price (from $25) at...\" data-tweet=\"$FANG - Diamondback Energy (FANG +3.2%) is raised to Buy from Hold with a $35 target price (from $25) at Wunderlich, which believes strong results from 13 Wolfcamp B-targeted horizontal wells (11 operated) shows the operational expertise, asset strength... https://seekingalpha.com/news/1030041?source=tweet\" data-url=\"https://seekingalpha.com/news/1030041\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1030001\" data-ts=\"1368721006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DELL\" target=\"_blank\">DELL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1030001\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco JV partner EMC (EMC +4.5%) joins the list of companies rallying in response to Cisco&#39;s FQ3...</a></h4><p>Cisco JV partner EMC (EMC <font color=\"green\">+4.5%</font>) joins the list of companies rallying in response to Cisco's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1027811\">FQ3 beat</a> and <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1028201\">guidance</a>. Cisco mentioned on its <a target=\"_blank\" href=\"https://seekingalpha.com/article/1438471-cisco-systems-ceo-discusses-f3q13-results-earnings-call-transcript\">earnings call</a> integrated hardware solutions such as <a target=\"_blank\" href=\"http://www.vce.com/products/vblock/overview\">Vblock</a> (offered by the Cisco/EMC VCE JV) are driving demand for its UCS servers - Cisco's UCS unit saw 77% Y/Y rev. growth. All in all, it's a good day for enterprise IT names, who are happy to receive some good earnings news after getting plenty of bad news (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/954261\">I</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/900511\">II</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/953321\">III</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/913451\">IV</a>). <a href=\"https://seekingalpha.com/symbol/HPQ\" title=\"HP Inc.\">HPQ</a> <font color=\"green\">+1.7%</font>. <a href=\"https://seekingalpha.com/symbol/IBM\" title=\"International Business Machines Corporation\">IBM</a> <font color=\"green\">+1.3%</font>. <a href=\"https://seekingalpha.com/symbol/ORCL\" title=\"Oracle Corporation\">ORCL</a> <font color=\"green\">+1.3%</font>. <a href=\"https://seekingalpha.com/symbol/VMW\" title=\"VMware, Inc.\">VMW</a> <font color=\"green\">+2.6%</font>. <a href=\"https://seekingalpha.com/symbol/TIBX\" title=\"TIBCO Software, Inc.\">TIBX</a> <font color=\"green\">+4.1%</font>. <a href=\"https://seekingalpha.com/symbol/CTXS\" title=\"Citrix Systems, Inc.\">CTXS</a> <font color=\"green\">+3.9%</font>. <a href=\"https://seekingalpha.com/symbol/CRM\" title=\"Salesforce.com, Inc.\">CRM</a> <font color=\"green\">+3.8%</font>. <a href=\"https://seekingalpha.com/symbol/JIVE\" title=\"Jive Software\">JIVE</a> <font color=\"green\">+4.1%</font>. <a href=\"https://seekingalpha.com/symbol/NTGR\" title=\"NETGEAR, Inc.\">NTGR</a> <font color=\"green\">+2.7%</font>. <a href=\"https://seekingalpha.com/symbol/CVLT\" title=\"CommVault Systems, Inc.\">CVLT</a> <font color=\"green\">+2.6%</font>. <a href=\"https://seekingalpha.com/symbol/INFA\" title=\"Informatica Corporation\">INFA</a> <font color=\"green\">+3%</font>. (others rallying: <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1029771\">I</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1029401\">II</a>)</p><div class=\"tiny-share-widget\" data-id=\"1030001\" data-linked=\"Cisco JV partner EMC (EMC +4.5%) joins the list of companies rallying in response to Cisco&#39;s FQ3...\" data-tweet=\"$DELL $DELL $HPQ - Cisco JV partner EMC (EMC +4.5%) joins the list of companies rallying in response to Cisco&#39;s FQ3 beat and guidance. Cisco mentioned on its earnings call integrated hardware solutions such as Vblock (offered by the Cisco/EMC VCE JV) ar... https://seekingalpha.com/news/1030001?source=tweet\" data-url=\"https://seekingalpha.com/news/1030001\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029991\" data-ts=\"1368720806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029991\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush doesn&#39;t find any love in Halozyme Therapeutics (HALO +16.6%) ASCO presentation earlier...</a></h4><p>Wedbush doesn't find any love in Halozyme Therapeutics (<a href=\"https://seekingalpha.com/symbol/HALO\" title=\"Halozyme Therapeutics, Inc.\">HALO</a> <font color=\"green\">+16.6%</font>) <a href=\"https://seekingalpha.com/market_currents/post/1029431\" target=\"_blank\">ASCO presentation</a> earlier today regarding clinical data from a Phase 1b trial of PEGPH20 that showed it helps to break down pancreatic cancers. The firm says that a positive tumor response outcome was expected. However, serial comparative PET imaging is a potentially more biologically relevant measure of disease activity, and it continues to expect a <a href=\"http://www.streetinsider.com/Analyst+Comments/Wedbush+Sees+No+Need+to+Own+Halozyme+%28HALO%29/8346747.html\" target=\"_blank\">negative recommendation</a> from the EMA on the approval of sub-cu Herceptin in Q2.</p><div class=\"tiny-share-widget\" data-id=\"1029991\" data-linked=\"Wedbush doesn&#39;t find any love in Halozyme Therapeutics (HALO +16.6%) ASCO presentation earlier...\" data-tweet=\"$HALO - Wedbush doesn&#39;t find any love in Halozyme Therapeutics (HALO +16.6%) ASCO presentation earlier today regarding clinical data from a Phase 1b trial of PEGPH20 that showed it helps to break down pancreatic cancers. The firm says that a positive tu... https://seekingalpha.com/news/1029991?source=tweet\" data-url=\"https://seekingalpha.com/news/1029991\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029981\" data-ts=\"1368720745\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JACK\" target=\"_blank\">JACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029981\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jack in the Box (JACK -4.9%) slips after Wednesday&#39;s Q2 report. Same-store sales at Jack in the...</a></h4><p>Jack in the Box (<a href=\"https://seekingalpha.com/symbol/JACK\" title=\"Jack In The Box Inc.\">JACK</a> <font color=\"red\">-4.9%</font>) slips after Wednesday's <a href=\"https://seekingalpha.com/currents/post/1027791\" target=\"_blank\">Q2 report</a>. Same-store sales at Jack in the Box rose 0.9% Y/Y while comps at Qdoba fell 2%, hit by severe weather. For Q3 the company sees same-store sales growth of 1-3% versus 3.4% in Q3 2012 at Jack in the Box. Qdoba comps should be flat next quarter versus growth of 3.3% in the same period last year. For the full year, JACK sees $1.55-1.65 per share (consensus is $1.61). (PR)</p><div class=\"tiny-share-widget\" data-id=\"1029981\" data-linked=\"Jack in the Box (JACK -4.9%) slips after Wednesday&#39;s Q2 report. Same-store sales at Jack in the...\" data-tweet=\"$JACK - Jack in the Box (JACK -4.9%) slips after Wednesday&#39;s Q2 report. Same-store sales at Jack in the Box rose 0.9% Y/Y while comps at Qdoba fell 2%, hit by severe weather. For Q3 the company sees same-store sales growth of 1-3% versus 3.4% in Q3 2012... https://seekingalpha.com/news/1029981?source=tweet\" data-url=\"https://seekingalpha.com/news/1029981\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029971\" data-ts=\"1368720439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTAP\" target=\"_blank\">NTAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029971\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NetApp (NTAP +7.1%) soars on a report activist firm Elliott Associates has taken a sub-5% stake...</a></h4>NetApp (<a href='https://seekingalpha.com/symbol/NTAP' title='NetApp, Inc.'>NTAP</a> <font color=\"green\">+7.1%</font>) soars on a report activist firm Elliott Associates has <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2013-05-16/netapp-is-said-to-be-pushed-by-elliott-to-change-its-board-1-.html\">taken a sub-5% stake</a> (could grow larger in time) in the company, and is pushing it to \"change its board and study options to boost shareholder value.\" Elliott is fresh off <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1000411\">a successful push</a> to get BMC Software to sell itself. The news comes ahead of NetApp's Tuesday FQ4 report. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1022101\">dealReporter</a>)<div class=\"tiny-share-widget\" data-id=\"1029971\" data-linked=\"NetApp (NTAP +7.1%) soars on a report activist firm Elliott Associates has taken a sub-5% stake...\" data-tweet=\"$NTAP - NetApp (NTAP +7.1%) soars on a report activist firm Elliott Associates has taken a sub-5% stake (could grow larger in time) in the company, and is pushing it to &quot;change its board and study options to boost shareholder value.&quot; Elliott is fresh of... https://seekingalpha.com/news/1029971?source=tweet\" data-url=\"https://seekingalpha.com/news/1029971\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029941\" data-ts=\"1368719454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUB\" target=\"_blank\">CUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029941\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cubic (CUB +5%) trades up today after pricing a secondary public offering of 2.3M shares at...</a></h4><p>Cubic (<a href=\"https://seekingalpha.com/symbol/CUB\" title=\"Cubic Corporation\">CUB</a> <font color=\"green\">+5%</font>) trades up today after pricing a secondary public offering of 2.3M shares at $45.75, just a nominal discount to yesterday's close. All shares were offered by <a href=\"https://seekingalpha.com/symbol/CUB\" title=\"Cubic Corporation\">CUB</a> shareholders comprised of trusts created by its founder, Walter J. Zable, who passed away in 2012. The selling shareholders, who will receive all of the net proceeds from the offering, have granted the underwriters an option for 30 days to purchase up to 350K additional shares.</p><div class=\"tiny-share-widget\" data-id=\"1029941\" data-linked=\"Cubic (CUB +5%) trades up today after pricing a secondary public offering of 2.3M shares at...\" data-tweet=\"$CUB - Cubic (CUB +5%) trades up today after pricing a secondary public offering of 2.3M shares at $45.75, just a nominal discount to yesterday&#39;s close. All shares were offered by CUB shareholders comprised of trusts created by its founder, Walter J. Za... https://seekingalpha.com/news/1029941?source=tweet\" data-url=\"https://seekingalpha.com/news/1029941\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029931\" data-ts=\"1368719336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TAT\" target=\"_blank\">TAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029931\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TransAtlantic Petroleum (TAT +5.3%) expects Q1 revenues of $33M-$37M and net earnings between a...</a></h4><p>TransAtlantic Petroleum (<a href=\"https://seekingalpha.com/symbol/TAT\" title=\"TransAtlantic Petroleum Ltd.\">TAT</a> <font color=\"green\">+5.3%</font>) expects Q1 revenues of $33M-$37M and net earnings between a $2M loss and $6M gain. Says it had ~$19M in cash and ~$40M in long-term debt at the end of Q1.</p><div class=\"tiny-share-widget\" data-id=\"1029931\" data-linked=\"TransAtlantic Petroleum (TAT +5.3%) expects Q1 revenues of $33M-$37M and net earnings between a...\" data-tweet=\"$TAT - TransAtlantic Petroleum (TAT +5.3%) expects Q1 revenues of $33M-$37M and net earnings between a $2M loss and $6M gain. Says it had ~$19M in cash and ~$40M in long-term debt at the end of Q1. https://seekingalpha.com/news/1029931?source=tweet\" data-url=\"https://seekingalpha.com/news/1029931\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029911\" data-ts=\"1368719135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDAP\" target=\"_blank\">EDAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029911\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Edap (EDAP -3.5%) falls after missing the one available analyst EPS estimate, although revenues...</a></h4><p>Edap (<a href=\"https://seekingalpha.com/symbol/EDAP\" title=\"EDAP TMS S.A.\">EDAP</a> <font color=\"red\">-3.5%</font>) falls after <a href=\"https://seekingalpha.com/currents/post/1029851\" target=\"_blank\">missing</a> the one available analyst EPS estimate, although revenues beat by a slim margin and <font color=\"green\">rise 23%</font> Y/Y on \"strong demand for [the company's] innovative lithotripsy product range in key global markets.\" CEO Marc Oczachowski says the \"FDA process for Ablatherm-HIFU is on track.\" Profit margins fall 220 basis points Y/Y on a negative yen impact and operating expenses increase 9.7% on \"continued regulatory expenses associated with the PMA filing for Ablatherm-HIFU, as well as sales and marketing investments.\" (PR)</p><div class=\"tiny-share-widget\" data-id=\"1029911\" data-linked=\"Edap (EDAP -3.5%) falls after missing the one available analyst EPS estimate, although revenues...\" data-tweet=\"$EDAP - Edap (EDAP -3.5%) falls after missing the one available analyst EPS estimate, although revenues beat by a slim margin and rise 23% Y/Y on &quot;strong demand for [the company&#39;s] innovative lithotripsy product range in key global markets.&quot; CEO Marc Oc... https://seekingalpha.com/news/1029911?source=tweet\" data-url=\"https://seekingalpha.com/news/1029911\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029891\" data-ts=\"1368718750\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBL\" target=\"_blank\">NBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rosetta Resources (ROSE +3.5%) is upgraded to Outperform with a $63-$67 price target, up from...</a></h4><p>Rosetta Resources (<a href=\"https://seekingalpha.com/symbol/ROSE\" title=\"Rosehill Resources Inc.\">ROSE</a> <font color=\"green\">+3.5%</font>) is <a href=\"http://www.streetinsider.com/Upgrades/Wells+Fargo+Upgrades+Rosetta+Resources+%28ROSE%29+to+Outperform%2C+Shares+Attractive/8345876.html\" target=\"_blank\">upgraded</a> to Outperform with a $63-$67 price target, up from $52-$56, at Wells Fargo, which likes the direction the company is headed. Concerns about inventory and long-term production growth visibility have been effectively removed thanks to the Permian acquisition, and with financing of the transaction addressed, the firm finds  shares attractively priced.</p><div class=\"tiny-share-widget\" data-id=\"1029891\" data-linked=\"Rosetta Resources (ROSE +3.5%) is upgraded to Outperform with a $63-$67 price target, up from...\" data-tweet=\"$NBL - Rosetta Resources (ROSE +3.5%) is upgraded to Outperform with a $63-$67 price target, up from $52-$56, at Wells Fargo, which likes the direction the company is headed. Concerns about inventory and long-term production growth visibility have been ... https://seekingalpha.com/news/1029891?source=tweet\" data-url=\"https://seekingalpha.com/news/1029891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029861\" data-ts=\"1368718474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FXE\" target=\"_blank\">FXE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029861\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The euro tumbles about 30 pips as European Industry Commissioner Antonio Tajani tabs the...</a></h4>The euro tumbles about 30 pips as European Industry Commissioner Antonio Tajani tabs the currency as <a href=\"https://twitter.com/livesquawk/status/335053147909275650\" target=\"_blank\">too strong</a> and calls on the ECB to manage its level to better-help exports. <a href='https://seekingalpha.com/symbol/FXE' title='Invesco CurrencyShares Euro Trust ETF'>FXE</a> now <font color=\"green\">up just 0.1%</font>.<div class=\"tiny-share-widget\" data-id=\"1029861\" data-linked=\"The euro tumbles about 30 pips as European Industry Commissioner Antonio Tajani tabs the...\" data-tweet=\"$FXE $ULE $ERO - The euro tumbles about 30 pips as European Industry Commissioner Antonio Tajani tabs the currency as too strong and calls on the ECB to manage its level to better-help exports. FXE now up just 0.1%. https://seekingalpha.com/news/1029861?source=tweet\" data-url=\"https://seekingalpha.com/news/1029861\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029841\" data-ts=\"1368717931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HES\" target=\"_blank\">HES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029841\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hess&#39; (HES -2%) deal to resolve its proxy fight with Elliott Management is a win-win, Deutsche...</a></h4><p>Hess' (<a href=\"https://seekingalpha.com/symbol/HES\" title=\"Hess Corporation\">HES</a> <font color=\"red\">-2%</font>) deal to <a href=\"https://seekingalpha.com/currents/post/1029311\" target=\"_blank\">resolve its proxy fight</a> with Elliott Management is a <a href=\"http://www.streetinsider.com/Analyst+Comments/Hess+Corporation+%28HES%29+Situation+Win-Win%2C+Says+Analyst/8346706.html\" target=\"_blank\">win-win</a>, Deutsche Bank's Paul Sankey says in maintaining his Buy rating and $80 price target. Had Elliott's dissident  director slate lost, lots of activist  money in the stock - not just Elliott - might have fled; had Hess\u2019 slate lost, concern about a split board and a long  strategy review might have undermined some of Hess' recent positive moves.</p><div class=\"tiny-share-widget\" data-id=\"1029841\" data-linked=\"Hess&#39; (HES -2%) deal to resolve its proxy fight with Elliott Management is a win-win, Deutsche...\" data-tweet=\"$HES - Hess&#39; (HES -2%) deal to resolve its proxy fight with Elliott Management is a win-win, Deutsche Bank&#39;s Paul Sankey says in maintaining his Buy rating and $80 price target. Had Elliott&#39;s dissident director slate lost, lots of activist money in the ... https://seekingalpha.com/news/1029841?source=tweet\" data-url=\"https://seekingalpha.com/news/1029841\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029811\" data-ts=\"1368716424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYCC\" target=\"_blank\">CYCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029811\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Cyclacel Pharmaceuticals (CYCC -13.5%) take a hit after it prices its previously...</a></h4><p>Shares of Cyclacel Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/CYCC\" title=\"Cyclacel Pharmaceuticals, Inc.\">CYCC</a> <font color=\"red\">-13.5%</font>) take a hit after it prices its <a href=\"1028301\" target=\"_blank\">previously announced</a> public offering of 6.7 million shares at $3.00 each, a sharp 13% discount to its previous session close of $3.47. All of the shares are being sold by <a href=\"https://seekingalpha.com/symbol/CYCC\" title=\"Cyclacel Pharmaceuticals, Inc.\">CYCC</a>, and the proceeds will be used primarily to complete Phase 3 trials of its lead drug candidate, sapacitabine.</p><div class=\"tiny-share-widget\" data-id=\"1029811\" data-linked=\"Shares of Cyclacel Pharmaceuticals (CYCC -13.5%) take a hit after it prices its previously...\" data-tweet=\"$CYCC - Shares of Cyclacel Pharmaceuticals (CYCC -13.5%) take a hit after it prices its previously announced public offering of 6.7 million shares at $3.00 each, a sharp 13% discount to its previous session close of $3.47. All of the shares are being so... https://seekingalpha.com/news/1029811?source=tweet\" data-url=\"https://seekingalpha.com/news/1029811\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029801\" data-ts=\"1368716376\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRS\" target=\"_blank\">AMRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029801\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amyris (AMRS -5.6%) takes a hit after the company is implicated in a class action lawsuit which...</a></h4><p>Amyris (<a href=\"https://seekingalpha.com/symbol/AMRS\" title=\"Amyris, Inc.\">AMRS</a> <font color=\"red\">-5.6%</font>) takes a hit after the company is implicated in a class action lawsuit which claims it misled investors in 2011 and 2012 about its ability to produce Biofene in \"commercially meaningful volumes.\" When the company changed its tone about production levels, the stock ultimately fell 48% from November 2011 to February 2012. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1029801\" data-linked=\"Amyris (AMRS -5.6%) takes a hit after the company is implicated in a class action lawsuit which...\" data-tweet=\"$AMRS - Amyris (AMRS -5.6%) takes a hit after the company is implicated in a class action lawsuit which claims it misled investors in 2011 and 2012 about its ability to produce Biofene in &quot;commercially meaningful volumes.&quot; When the company changed its t... https://seekingalpha.com/news/1029801?source=tweet\" data-url=\"https://seekingalpha.com/news/1029801\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029771\" data-ts=\"1368715780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIAV\" target=\"_blank\">VIAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029771\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plenty of Cisco rivals and suppliers are now rallying in response to the company&#39;s FQ3 beat,...</a></h4><p>Plenty of Cisco rivals and suppliers are now rallying in response to the company's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1027811\">FQ3 beat</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1028201\">guidance</a>, and <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1028361\">order activity</a>: JDSU <font color=\"green\">+5.2%</font>. <a href=\"https://seekingalpha.com/symbol/RKUS\" title=\"Ruckus Wireless\">RKUS</a> <font color=\"green\">+5.8%</font>. CAVM <font color=\"green\">+4.8%</font>. <a href=\"https://seekingalpha.com/symbol/PKT\" title=\"Procera Networks, Inc\">PKT</a> <font color=\"green\">+2.9%</font>. <a href=\"https://seekingalpha.com/symbol/ADTN\" title=\"ADTRAN, Inc.\">ADTN</a> <font color=\"green\">+2.6%</font>. <a href=\"https://seekingalpha.com/symbol/ALLT\" title=\"Allot Communications Ltd.\">ALLT</a> <font color=\"green\">+1.9%</font>. <a href=\"https://seekingalpha.com/symbol/FN\" title=\"Fabrinet\">FN</a> <font color=\"green\">+2%</font>. <a href=\"https://seekingalpha.com/symbol/FNSR\" title=\"Finisar Corporation\">FNSR</a> <font color=\"green\">+2.4%</font>. BRCM <font color=\"green\">+1.3%</font>. <a href=\"https://seekingalpha.com/symbol/MRVL\" title=\"Marvell Technology Group, Ltd.\">MRVL</a> <font color=\"green\">+1.6%</font>. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1029401\">previous</a>)</p><div class=\"tiny-share-widget\" data-id=\"1029771\" data-linked=\"Plenty of Cisco rivals and suppliers are now rallying in response to the company&#39;s FQ3 beat,...\" data-tweet=\"$VIAV $VIAV $RKUS - Plenty of Cisco rivals and suppliers are now rallying in response to the company&#39;s FQ3 beat, guidance, and order activity: JDSU +5.2%. RKUS +5.8%. CAVM +4.8%. PKT +2.9%. ADTN +2.6%. ALLT +1.9%. FN +2%. FNSR +2.4%. BRCM +1.3%. MRVL +1... https://seekingalpha.com/news/1029771?source=tweet\" data-url=\"https://seekingalpha.com/news/1029771\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029761\" data-ts=\"1368715637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029761\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chesapeake Energy (CHK -2.6%) is downgraded to Neutral from Overweight at J.P. Morgan, which...</a></h4>Chesapeake Energy (<a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color=\"red\">-2.6%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/05/3596345/update-j-p-morgan-downgrades-chesapeake-energy-on-valuat#\" target=\"_blank\">downgraded</a> to Neutral from Overweight at J.P. Morgan, which cites valuation, a lack of visible catalysts and a \"perpetual funding gap\" that could total $9.3B by 2015. The firm believes planned asset sales will help CHK fund its cash outspend in 2013 but will need to take on debt in 2014-15.<div class=\"tiny-share-widget\" data-id=\"1029761\" data-linked=\"Chesapeake Energy (CHK -2.6%) is downgraded to Neutral from Overweight at J.P. Morgan, which...\" data-tweet=\"$CHK - Chesapeake Energy (CHK -2.6%) is downgraded to Neutral from Overweight at J.P. Morgan, which cites valuation, a lack of visible catalysts and a &quot;perpetual funding gap&quot; that could total $9.3B by 2015. The firm believes planned asset sales will hel... https://seekingalpha.com/news/1029761?source=tweet\" data-url=\"https://seekingalpha.com/news/1029761\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029741\" data-ts=\"1368715566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBOT\" target=\"_blank\">MBOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029741\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of stem cell research firms are rallying today on the back of an announcement today by...</a></h4><p>Shares of stem cell research firms are rallying today on the back of an announcement today by the Oregon Health and Science University that they've <a href=\"http://www.nytimes.com/2013/05/16/science/scientists-use-cloning-to-create-embryonic-stem-cells.html?_r=0\" target=\"_blank\">successfully reproduced human stem cells by cloning</a>. Cloning stem cells in this fashion could lead to cell therapies using a patient\u2019s own cells and thereby avoid the problems of immune suppression: StemCells (STEM <font color=\"green\">+2.2%</font>), NeuralStem (<a href=\"https://seekingalpha.com/symbol/CUR\" title=\"Neuralstem, Inc.\">CUR</a> <font color=\"green\">+2.1%</font>),  NeoStem (NBS <font color=\"green\">+2.2%</font>).</p><div class=\"tiny-share-widget\" data-id=\"1029741\" data-linked=\"Shares of stem cell research firms are rallying today on the back of an announcement today by...\" data-tweet=\"$MBOT $MBOT $SNCA - Shares of stem cell research firms are rallying today on the back of an announcement today by the Oregon Health and Science University that they&#39;ve successfully reproduced human stem cells by cloning. Cloning stem cells in this fashi... https://seekingalpha.com/news/1029741?source=tweet\" data-url=\"https://seekingalpha.com/news/1029741\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029731\" data-ts=\"1368714996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JE\" target=\"_blank\">JE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029731\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Just Energy (JE +4.1%) rises after reporting FQ4 and FY13 results. From the report: Annual...</a></h4><p>Just Energy (<a href=\"https://seekingalpha.com/symbol/JE\" title=\"Just Energy Group, Inc.\">JE</a> <font color=\"green\">+4.1%</font>) rises after reporting FQ4 and FY13 <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1029681\">results</a>. From the report: Annual customer additions hit a record 1.355M and increase 24% Y/Y while the customer base grows 10% Y/Y to 4.46M. Gross margin expansion and embedded gross margin expansion of 5% and 15% respectively. Outlook: FY14 EBITDA of $220M (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/909591\">previously announced</a>), long-term payout of 60-65% on FFO by H2 2016. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1029731\" data-linked=\"Just Energy (JE +4.1%) rises after reporting FQ4 and FY13 results. From the report: Annual...\" data-tweet=\"$JE - Just Energy (JE +4.1%) rises after reporting FQ4 and FY13 results. From the report: Annual customer additions hit a record 1.355M and increase 24% Y/Y while the customer base grows 10% Y/Y to 4.46M. Gross margin expansion and embedded gross margin... https://seekingalpha.com/news/1029731?source=tweet\" data-url=\"https://seekingalpha.com/news/1029731\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029621\" data-ts=\"1368713108\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029621\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper raises its estimates for Pandora (P +1.9%) ahead of next Thursday&#39;s FQ1 report, citing...</a></h4><a target=\"_blank\" href=\"http://finance.yahoo.com/news/analysts-actions-amd-amzn-chk-121900867.html\">Piper raises its estimates</a> for Pandora (<a href=\"https://seekingalpha.com/symbol/P\" title=\"Pandora Media\">P</a> <font color=\"green\">+1.9%</font>) ahead of next Thursday's FQ1 report, citing improved mobile monetization. Strong <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/875421\">mobile ad sales growth</a> was a key reason Pandora took off following its FQ4 report, but the company's mobile ad prices were still only <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/876221\">at 56% of PC levels</a>. (<a href=\"https://seekingalpha.com/currents/post/924661\" target=\"_blank\">eMarketer estimates</a>)<div class=\"tiny-share-widget\" data-id=\"1029621\" data-linked=\"Piper raises its estimates for Pandora (P +1.9%) ahead of next Thursday&#39;s FQ1 report, citing...\" data-tweet=\"$P - Piper raises its estimates for Pandora (P +1.9%) ahead of next Thursday&#39;s FQ1 report, citing improved mobile monetization. Strong mobile ad sales growth was a key reason Pandora took off following its FQ4 report, but the company&#39;s mobile ad prices ... https://seekingalpha.com/news/1029621?source=tweet\" data-url=\"https://seekingalpha.com/news/1029621\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029561\" data-ts=\"1368712308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029561\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SolarCity (SCTY +7.8%) teams up with Goldman to offer $500M+ in lease financing for...</a></h4><p>SolarCity (SCTY <font color=\"green\">+7.8%</font>) teams up with Goldman to offer $500M+ in lease financing for residential/commercial solar projects, expanding a deal created in 2012. The financing is good for an estimated 110MW, and the companies claim the program \"is the largest of its kind announced in the U.S. for homeowners rooftops.\" SolarCity is rallying once again thanks to the news.</p><div class=\"tiny-share-widget\" data-id=\"1029561\" data-linked=\"SolarCity (SCTY +7.8%) teams up with Goldman to offer $500M+ in lease financing for...\" data-tweet=\"$TSLA - SolarCity (SCTY +7.8%) teams up with Goldman to offer $500M+ in lease financing for residential/commercial solar projects, expanding a deal created in 2012. The financing is good for an estimated 110MW, and the companies claim the program &quot;is th... https://seekingalpha.com/news/1029561?source=tweet\" data-url=\"https://seekingalpha.com/news/1029561\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029501\" data-ts=\"1368711611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029501\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barrick Gold (ABX -3.2%) is downgraded to Underperform from Neutral with an $18 price target...</a></h4><p>Barrick Gold (ABX <font color=\"red\">-3.2%</font>) is <a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Macquarie+Downgrades+Barrick+Gold+%28ABX%29+to+Underperform/8346006.html\" target=\"_blank\">downgraded</a> to Underperform from Neutral with an $18 price target (from $21.50) at Macquarie, which views ABX as a mature company  with few opportunities to grow and high debt. The firm calls ABX's recent amendment to its Dominican Republic mine contract a  dangerous precedent.</p><div class=\"tiny-share-widget\" data-id=\"1029501\" data-linked=\"Barrick Gold (ABX -3.2%) is downgraded to Underperform from Neutral with an $18 price target...\" data-tweet=\"$GOLD - Barrick Gold (ABX -3.2%) is downgraded to Underperform from Neutral with an $18 price target (from $21.50) at Macquarie, which views ABX as a mature company with few opportunities to grow and high debt. The firm calls ABX&#39;s recent amendment to i... https://seekingalpha.com/news/1029501?source=tweet\" data-url=\"https://seekingalpha.com/news/1029501\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029481\" data-ts=\"1368711293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029481\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD (AMD -12.9%) opens sharply lower on a downgrade to Sell from Goldman, which doesn&#39;t see the...</a></h4><p>AMD (<a href=\"https://seekingalpha.com/symbol/AMD\" title=\"Advanced Micro Devices, Inc.\">AMD</a> <font color=\"red\">-12.9%</font>) opens sharply lower on a <a href=\"http://www.marketwatch.com/story/advanced-micro-devices-cut-to-sell-at-goldman-2013-05-16\" target=\"_blank\">downgrade to Sell</a> from Goldman, which doesn't see the chipmaker's <a href=\"https://seekingalpha.com/currents/post/1021991\" target=\"_blank\">giant spring rally</a> as justified. \"As has been the case with many of the other rallies in AMD, which have all faded, ultimately, the numbers do not justify the move in the stock ... we expect continued disappointing results in the PC segment to mitigate the impact of increased revenue from gaming.\" Goldman <a href=\"https://seekingalpha.com/currents/post/530121\" target=\"_blank\">upgraded AMD to Neutral</a> last September, when shares were at $3.47.</p><div class=\"tiny-share-widget\" data-id=\"1029481\" data-linked=\"AMD (AMD -12.9%) opens sharply lower on a downgrade to Sell from Goldman, which doesn&#39;t see the...\" data-tweet=\"$AMD - AMD (AMD -12.9%) opens sharply lower on a downgrade to Sell from Goldman, which doesn&#39;t see the chipmaker&#39;s giant spring rally as justified. &quot;As has been the case with many of the other rallies in AMD, which have all faded, ultimately, the number... https://seekingalpha.com/news/1029481?source=tweet\" data-url=\"https://seekingalpha.com/news/1029481\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029461\" data-ts=\"1368710862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRC\" target=\"_blank\">BRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029461\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brady Corp. (NYSE:BRC): Q1 EPS of $0.55 misses by $0.05. Revenue of $305M (+11% Y/Y) misses by...</a></h4><strong>Brady Corp. (NYSE:<a href=\"https://seekingalpha.com/symbol/BRC\" title=\"Brady Corporation\">BRC</a>):</strong> Q1 EPS of $0.55 <font color=\"red\">misses by $0.05</font>. Revenue of $305M (+11% Y/Y) <font color=\"red\">misses by $63M</font>. Shares <font color=\"red\">-7.2%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1029461\" data-linked=\"Brady Corp. (NYSE:BRC): Q1 EPS of $0.55 misses by $0.05. Revenue of $305M (+11% Y/Y) misses by...\" data-tweet=\"$BRC - Brady Corp. (NYSE:BRC): Q1 EPS of $0.55 misses by $0.05. Revenue of $305M (+11% Y/Y) misses by $63M. Shares -7.2% AH. (PR) https://seekingalpha.com/news/1029461?source=tweet\" data-url=\"https://seekingalpha.com/news/1029461\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029451\" data-ts=\"1368710775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029451\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palo Alto Networks (NYSE:PANW) +4% following an upgrade to Overweight from Morgan Stanley. The...</a></h4>Palo Alto Networks (NYSE:<a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a>) <font color=\"green\">+4%</font> following an <a href=\"http://www.streetinsider.com/Upgrades/Morgan+Stanley+Upgrades+Palo+Alto+Networks+%28PANW%29+to+Overweight/8345837.html\" target=\"_blank\">upgrade to Overweight</a> from Morgan Stanley. The upgrade comes ahead of Palo Alto's May 30 FQ3 report. Cisco, which Palo Alto has been taking firewall share from (along with Juniper and Check Point), reported a <a href=\"https://seekingalpha.com/currents/post/1028361\" target=\"_blank\">4% Y/Y drop</a> in security sales yesterday afternoon.<div class=\"tiny-share-widget\" data-id=\"1029451\" data-linked=\"Palo Alto Networks (NYSE:PANW) +4% following an upgrade to Overweight from Morgan Stanley. The...\" data-tweet=\"$PANW - Palo Alto Networks (NYSE:PANW) +4% following an upgrade to Overweight from Morgan Stanley. The upgrade comes ahead of Palo Alto&#39;s May 30 FQ3 report. Cisco, which Palo Alto has been taking firewall share from (along with Juniper and Check Point),... https://seekingalpha.com/news/1029451?source=tweet\" data-url=\"https://seekingalpha.com/news/1029451\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029431\" data-ts=\"1368710313\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029431\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halozyme Therapeutics (NASDAQ:HALO) jumps 7.57% premarket after saying Wednesday evening that...</a></h4><p>Halozyme Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HALO\" title=\"Halozyme Therapeutics, Inc.\">HALO</a>) <font color=\"green\">jumps 7.57%</font> premarket after saying Wednesday evening that data from a Phase 1b study supports the contention that PEGPH20 helps break down a protective matrix which surrounds most pancreatic cancers, making the disease more vulnerable to therapy. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1029431\" data-linked=\"Halozyme Therapeutics (NASDAQ:HALO) jumps 7.57% premarket after saying Wednesday evening that...\" data-tweet=\"$HALO - Halozyme Therapeutics (NASDAQ:HALO) jumps 7.57% premarket after saying Wednesday evening that data from a Phase 1b study supports the contention that PEGPH20 helps break down a protective matrix which surrounds most pancreatic cancers, making th... https://seekingalpha.com/news/1029431?source=tweet\" data-url=\"https://seekingalpha.com/news/1029431\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029401\" data-ts=\"1368710115\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029401\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A few Cisco rivals and suppliers are up premarket after the networking giant beat estimates...</a></h4><p>A few Cisco rivals and suppliers are up premarket after the networking giant <a href=\"https://seekingalpha.com/currents/post/1027811\" target=\"_blank\">beat estimates</a> while reporting strong data center switch/server sales and service provider orders (albeit while <a href=\"https://seekingalpha.com/currents/post/1028361\" target=\"_blank\">cautioning</a> the SP capex environment remains tough). Some others might move higher following the open. <a href=\"https://seekingalpha.com/symbol/JNPR\" title=\"Juniper Networks\">JNPR</a> <font color=\"green\">+3.6%</font>. <a href=\"https://seekingalpha.com/symbol/FFIV\" title=\"F5 Networks, Inc.\">FFIV</a> <font color=\"green\">+3.2%</font>. <a href=\"https://seekingalpha.com/symbol/CIEN\" title=\"Ciena Corporation\">CIEN</a> <font color=\"green\">+3.9%</font>. EZCH <font color=\"green\">+1.2%</font> - Cisco mentioned on its <a href=\"https://seekingalpha.com/article/1438471-cisco-systems-ceo-discusses-f3q13-results-earnings-call-transcript\" target=\"_blank\">earnings call</a> sales of its <a href=\"http://www.cisco.com/en/US/products/ps9853/index.html\" target=\"_blank\">ASR 9000 </a>edge routers, which EZchip supplies network processors for, were up 40%+ Y/Y.</p><div class=\"tiny-share-widget\" data-id=\"1029401\" data-linked=\"A few Cisco rivals and suppliers are up premarket after the networking giant beat estimates...\" data-tweet=\"$JNPR $JNPR $FFIV - A few Cisco rivals and suppliers are up premarket after the networking giant beat estimates while reporting strong data center switch/server sales and service provider orders (albeit while cautioning the SP capex environment remains ... https://seekingalpha.com/news/1029401?source=tweet\" data-url=\"https://seekingalpha.com/news/1029401\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029391\" data-ts=\"1368710048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGDX\" target=\"_blank\">RGDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029391\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: OTC:RGDX +24%. EGLE +23%. EFUT +19%. TSLA +13%. CSCO +13%. SCTY +11%. DQ +9%....</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/RGDX\" title=\"Response Genetics, Inc.\">OTC:RGDX</a> <font color=\"green\">+24%</font>. <a href=\"https://seekingalpha.com/symbol/EGLE\" title=\"Eagle Bulk Shipping Inc.\">EGLE</a> <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/EFUT\" title=\"e-Future Information Technology Inc.\">EFUT</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/CSCO\" title=\"Cisco Systems, Inc.\">CSCO</a> <font color=\"green\">+13%</font>. SCTY <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/DQ\" title=\"DAQO New Energy Corp.\">DQ</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/HALO\" title=\"Halozyme Therapeutics, Inc.\">HALO</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/DANG\" title=\"E-Commerce China Dangdang Inc.\">DANG</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/AV\" title=\"Aviva plc\">AV</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/YRCW\" title=\"YRC Worldwide, Inc.\">YRCW</a> <font color=\"green\">+8%</font>. NBG <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/KSS\" title=\"Kohl's Corporation\">KSS</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/SPWR\" title=\"SunPower Corporation\">SPWR</a> <font color=\"green\">+6%</font>. <br> <b>Losers:</b> NCT <font color=\"red\">-53%</font>. <a href=\"https://seekingalpha.com/symbol/SNFCA\" title=\"Security National Financial Corporation\">SNFCA</a> <font color=\"red\">-24%</font>. <a href=\"https://seekingalpha.com/symbol/AMD\" title=\"Advanced Micro Devices, Inc.\">AMD</a> <font color=\"red\">-10%</font>. NQ <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/CYCC\" title=\"Cyclacel Pharmaceuticals, Inc.\">CYCC</a> <font color=\"red\">-5%</font>.<div class=\"tiny-share-widget\" data-id=\"1029391\" data-linked=\"Premarket gainers: OTC:RGDX +24%. EGLE +23%. EFUT +19%. TSLA +13%. CSCO +13%. SCTY +11%. DQ +9%....\" data-tweet=\"$RGDX $RGDX $EGLE - Premarket gainers: OTC:RGDX +24%. EGLE +23%. EFUT +19%. TSLA +13%. CSCO +13%. SCTY +11%. DQ +9%. HALO +8%. DANG +7%. AV +7%. YRCW +8%. NBG +7%. KSS +7%. SPWR +6%. Losers: NCT -53%. SNFCA -24%. AMD -10%. NQ -7%. CYCC -5%. https://seekingalpha.com/news/1029391?source=tweet\" data-url=\"https://seekingalpha.com/news/1029391\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029341\" data-ts=\"1368709394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGLE\" target=\"_blank\">EGLE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029341\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eagle Bulk Shipping (NASDAQ:EGLE) soars 19.1% premarket after the company beat estimates with a...</a></h4><p>Eagle Bulk Shipping (NASDAQ:<a href=\"https://seekingalpha.com/symbol/EGLE\" title=\"Eagle Bulk Shipping Inc.\">EGLE</a>) <font color=\"green\">soars 19.1%</font> premarket after the company beat estimates with a large settlement helping to boost results. It's the first time shares have cleared $4 this year, but it could also be fleeting as the current with shipping stocks can reverse itself quickly.</p><div class=\"tiny-share-widget\" data-id=\"1029341\" data-linked=\"Eagle Bulk Shipping (NASDAQ:EGLE) soars 19.1% premarket after the company beat estimates with a...\" data-tweet=\"$EGLE - Eagle Bulk Shipping (NASDAQ:EGLE) soars 19.1% premarket after the company beat estimates with a large settlement helping to boost results. It&#39;s the first time shares have cleared $4 this year, but it could also be fleeting as the current with sh... https://seekingalpha.com/news/1029341?source=tweet\" data-url=\"https://seekingalpha.com/news/1029341\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029311\" data-ts=\"1368708878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HES\" target=\"_blank\">HES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029311\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hess (NYSE:HES) reaches agreement with Elliott Management is end its proxy contest. Hess adds...</a></h4><p>Hess (NYSE:<a href=\"https://seekingalpha.com/symbol/HES\" title=\"Hess Corporation\">HES</a>) reaches agreement with Elliott Management is end its proxy contest. Hess adds three of Elliott's director nominees. Elliott withdraws its slate of five nominees and supports election of Hess' five new directors. The reconstituted Board continues to consist of 14 people. Elliott is represented on the governance and compensation committees. Shares <font color=\"green\">+1.9%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1029311\" data-linked=\"Hess (NYSE:HES) reaches agreement with Elliott Management is end its proxy contest. Hess adds...\" data-tweet=\"$HES - Hess (NYSE:HES) reaches agreement with Elliott Management is end its proxy contest. Hess adds three of Elliott&#39;s director nominees. Elliott withdraws its slate of five nominees and supports election of Hess&#39; five new directors. The reconstituted ... https://seekingalpha.com/news/1029311?source=tweet\" data-url=\"https://seekingalpha.com/news/1029311\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029301\" data-ts=\"1368708694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029301\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel Nicolaus upgrades Constellation Brands (NYSE:STZ) to a Buy rating from Hold and places a...</a></h4><p>Stifel Nicolaus upgrades Constellation Brands (NYSE:<a href=\"https://seekingalpha.com/symbol/STZ\" title=\"Constellation Brands, Inc.\">STZ</a>) to a Buy rating from Hold and places a $64 price target on shares. Analysts with the firm think valuation is attractive at current levels with the company's higher-end beers outperforming peers. STZ <font color=\"green\">+1.5%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1029301\" data-linked=\"Stifel Nicolaus upgrades Constellation Brands (NYSE:STZ) to a Buy rating from Hold and places a...\" data-tweet=\"$STZ - Stifel Nicolaus upgrades Constellation Brands (NYSE:STZ) to a Buy rating from Hold and places a $64 price target on shares. Analysts with the firm think valuation is attractive at current levels with the company&#39;s higher-end beers outperforming p... https://seekingalpha.com/news/1029301?source=tweet\" data-url=\"https://seekingalpha.com/news/1029301\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029291\" data-ts=\"1368708458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBH\" target=\"_blank\">PBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029291\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prestige Brands (NYSE:PBH): FQ4 EPS of $0.36 beats by $0.01. FQ4 Revenue of $154.5M (+15.3% Y/Y)...</a></h4><b>Prestige Brands (NYSE:<a href=\"https://seekingalpha.com/symbol/PBH\" title=\"Prestige Brands Holdings, Inc.\">PBH</a>):</b> FQ4 EPS of $0.36 <font color=\"green\">beats by $0.01</font>. FQ4 Revenue of $154.5M (+15.3% Y/Y) <font color=\"red\">misses by $3.31M</font>. FY13 EPS of $1.50 <font color=\"green\">beats by $0.01</font>. FY13 revenue of $623.6M <font color=\"red\">misses by 3.43M</font>. Shares <font color=\"red\">-12.38%</font> premarket. (PR)<div class=\"tiny-share-widget\" data-id=\"1029291\" data-linked=\"Prestige Brands (NYSE:PBH): FQ4 EPS of $0.36 beats by $0.01. FQ4 Revenue of $154.5M (+15.3% Y/Y)...\" data-tweet=\"$PBH - Prestige Brands (NYSE:PBH): FQ4 EPS of $0.36 beats by $0.01. FQ4 Revenue of $154.5M (+15.3% Y/Y) misses by $3.31M. FY13 EPS of $1.50 beats by $0.01. FY13 revenue of $623.6M misses by 3.43M. Shares -12.38% premarket. (PR) https://seekingalpha.com/news/1029291?source=tweet\" data-url=\"https://seekingalpha.com/news/1029291\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029201\" data-ts=\"1368707333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRP\" target=\"_blank\">TRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029201\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TransCanada (NYSE:TRP) plans to sell down its stake in two natural gas pipelines to affiliated...</a></h4><font face=\"Arial\" class=\"NormalMinus1\">TransCanada (NYSE:<a href=\"https://seekingalpha.com/symbol/TRP\" title=\"TransCanada Corporation\">TRP</a>)  plans to <a href=\"http://www.foxbusiness.com/news/2013/05/15/transcanada-to-sell-pipelines-stake-to-tc-pipelines-for-04-million/\" target=\"_blank\">sell down its stake</a> in two natural gas pipelines to affiliated company TC PipeLines (NYSE:<a href=\"https://seekingalpha.com/symbol/TCP\" title=\"TC PipeLines, LP\">TCP</a>) in a ~$1B deal including debt, which it says will free up funds for capital investments. TCP <font color=\"red\">-2.8%</font> premarket after saying it would sell 7.7M units in an effort to raise funds for the acquisition.</font><div class=\"tiny-share-widget\" data-id=\"1029201\" data-linked=\"TransCanada (NYSE:TRP) plans to sell down its stake in two natural gas pipelines to affiliated...\" data-tweet=\"$TRP $TRP $TCP - TransCanada (NYSE:TRP) plans to sell down its stake in two natural gas pipelines to affiliated company TC PipeLines (NYSE:TCP) in a ~$1B deal including debt, which it says will free up funds for capital investments. TCP -2.8% premarket ... https://seekingalpha.com/news/1029201?source=tweet\" data-url=\"https://seekingalpha.com/news/1029201\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029091\" data-ts=\"1368705472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KSS\" target=\"_blank\">KSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029091\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Kohl&#39;s (NYSE:KSS) gain 7.1% premarket after the retailer beats profit estimates...</a></h4><p>Shares of Kohl's (NYSE:<a href=\"https://seekingalpha.com/symbol/KSS\" title=\"Kohl's Corporation\">KSS</a>) <font color=\"green\">gain 7.1%</font> premarket after the retailer <a href=\"https://seekingalpha.com/currents/post/1028971\" target=\"_blank\">beats</a> profit estimates handily and notes strengthening sales trends.</p><div class=\"tiny-share-widget\" data-id=\"1029091\" data-linked=\"Shares of Kohl&#39;s (NYSE:KSS) gain 7.1% premarket after the retailer beats profit estimates...\" data-tweet=\"$KSS - Shares of Kohl&#39;s (NYSE:KSS) gain 7.1% premarket after the retailer beats profit estimates handily and notes strengthening sales trends. https://seekingalpha.com/news/1029091?source=tweet\" data-url=\"https://seekingalpha.com/news/1029091\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029031\" data-ts=\"1368704556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGDX\" target=\"_blank\">RGDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029031\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Response Genetics (OTC:RGDX) jumps 29.63% premarket after announcing an agreement to join all of...</a></h4><p>Response Genetics (<a href=\"https://seekingalpha.com/symbol/RGDX\" title=\"Response Genetics, Inc.\">OTC:RGDX</a>) <font color=\"green\">jumps 29.63%</font> premarket after announcing an agreement to join all of Blue Shield of California's provider networks. This is the company's first Blue Cross Blue Shield contract. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1029031\" data-linked=\"Response Genetics (OTC:RGDX) jumps 29.63% premarket after announcing an agreement to join all of...\" data-tweet=\"$RGDX - Response Genetics (OTC:RGDX) jumps 29.63% premarket after announcing an agreement to join all of Blue Shield of California&#39;s provider networks. This is the company&#39;s first Blue Cross Blue Shield contract. (PR) https://seekingalpha.com/news/1029031?source=tweet\" data-url=\"https://seekingalpha.com/news/1029031\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029021\" data-ts=\"1368704435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMT\" target=\"_blank\">WMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029021\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More highlights from Wal-Mart (NYSE:WMT): 1) Legal expenses related to the bribery probe and...</a></h4><p>More highlights from Wal-Mart (NYSE:<a href=\"https://seekingalpha.com/symbol/WMT\" title=\"Walmart Inc.\">WMT</a>): 1) Legal expenses related to the bribery probe and FCPA issues are expected to be $65M-$70M in Q2. 2) The retailer sees U.S. stores comparable sales flat to +2% for Q2. 3) Sam's Club fees were increased on May 15 for Advantage (+$5) and Business (+$10) memberships, marking the first bump since 2006. In Q1, Sam's Club saw comp traffic up 1.3% while the average ticket was 1.1% lower. WMT <font color=\"red\">-2.4%</font> premarket. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1029021\" data-linked=\"More highlights from Wal-Mart (NYSE:WMT): 1) Legal expenses related to the bribery probe and...\" data-tweet=\"$WMT - More highlights from Wal-Mart (NYSE:WMT): 1) Legal expenses related to the bribery probe and FCPA issues are expected to be $65M-$70M in Q2. 2) The retailer sees U.S. stores comparable sales flat to +2% for Q2. 3) Sam&#39;s Club fees were increased o... https://seekingalpha.com/news/1029021?source=tweet\" data-url=\"https://seekingalpha.com/news/1029021\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1029011\" data-ts=\"1368704337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1029011\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco (NASDAQ:CSCO) is now up 9.4% premarket following last night&#39;s earnings&amp;nbsp;and guidance....</a></h4><p>Cisco (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CSCO\" title=\"Cisco Systems, Inc.\">CSCO</a>) is now<font color=\"green\"> up 9.4%</font> premarket following <a href=\"https://seekingalpha.com/currents/post/1027981\" target=\"_blank\">last night's earnings</a>and guidance. Lazard's Ryan Hitchinson notes guidance was light, but <a href=\"http://www.streetinsider.com/Analyst+Comments/Lazard+Keeps+Cisco+%28CSCO%29+at+Neutral%3B+Conservative+Guidance+Should+Ease+Concerns/8345469.html\" target=\"_blank\">likely beat </a>a lot of the whispers out there. He also believes management is remaining conservative amid improving demand trends. A bellwether no more, Cisco's moonshot is having little effect on the <a href=\"https://seekingalpha.com/symbol/QQQ\" title=\"Invesco QQQ ETF\">QQQ</a>s, which are barely green at the moment.</p><div class=\"tiny-share-widget\" data-id=\"1029011\" data-linked=\"Cisco (NASDAQ:CSCO) is now up 9.4% premarket following last night&#39;s earningsand guidance....\" data-tweet=\"$CSCO $CSCO $QQQ - Cisco (NASDAQ:CSCO) is now up 9.4% premarket following last night&#39;s earningsand guidance. Lazard&#39;s Ryan Hitchinson notes guidance was light, but likely beat a lot of the whispers out there. He also believes management is remaining co... https://seekingalpha.com/news/1029011?source=tweet\" data-url=\"https://seekingalpha.com/news/1029011\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1028961\" data-ts=\"1368703329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMT\" target=\"_blank\">WMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1028961\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Wal-Mart&#39;s (NYSE:WMT) Q1: Comparable-store sales dipped 1.4% during Q1 as the company...</a></h4><p>More on Wal-Mart's (NYSE:<a href=\"https://seekingalpha.com/symbol/WMT\" title=\"Walmart Inc.\">WMT</a>) Q1: Comparable-store sales dipped 1.4% during Q1 as the company says delayed income tax refunds and lousy weather cut into traffic. Revenue at Wal-Mart International grew 2.9% to $33B while Sam's Club sales were up just 0.1% to $13.87B. Traffic was down 1.8% across the company, a bigger drop than analysts forecast. A couple of bright spots during the quarter were booming e-commerce sales (+30%) and a gain in market share in the food, consumables and health &amp; wellness/OTC category. The retailer sees Q2 EPS of $1.22-$1.27 vs. $1.29 consensus. WMT <font color=\"red\">-1.8%</font> premarket to $78.40. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1028961\" data-linked=\"More on Wal-Mart&#39;s (NYSE:WMT) Q1: Comparable-store sales dipped 1.4% during Q1 as the company...\" data-tweet=\"$WMT - More on Wal-Mart&#39;s (NYSE:WMT) Q1: Comparable-store sales dipped 1.4% during Q1 as the company says delayed income tax refunds and lousy weather cut into traffic. Revenue at Wal-Mart International grew 2.9% to $33B while Sam&#39;s Club sales were up j... https://seekingalpha.com/news/1028961?source=tweet\" data-url=\"https://seekingalpha.com/news/1028961\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1028951\" data-ts=\"1368703080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1028951\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Precious metals continue to tumble, with gold at $1,374 nearing the panicky lows (about $1,350)...</a></h4><p>Precious metals continue to tumble, with gold at $1,374 <a href=\"http://finviz.com/futures_charts.ashx?t=GC\" target=\"_blank\">nearing the panicky lows</a> (about $1,350) seen during April's liquidation. Any excuse will do in a bear market, and <a href=\"http://www.bloomberg.com/news/2013-05-16/gold-near-1-month-low-as-soros-blackrock-reduce-etp-holdings.html?cmpid=yhoo\" target=\"_blank\">filings released yesterday</a> containing data anywhere from 6 weeks to 5 months old showed continuing sales of gold ETPs by names such as Soros and BlackRock. <a href=\"https://seekingalpha.com/symbol/gld\" title=\"SPDR Gold Trust ETF\">GLD</a> <font color=\"red\">-1.3%</font>, <a href=\"https://seekingalpha.com/symbol/slv\" title=\"iShares Silver Trust ETF\">SLV</a> <font color=\"red\">-1.3%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1028951\" data-linked=\"Precious metals continue to tumble, with gold at $1,374 nearing the panicky lows (about $1,350)...\" data-tweet=\"$GLD $SLV $GLD - Precious metals continue to tumble, with gold at $1,374 nearing the panicky lows (about $1,350) seen during April&#39;s liquidation. Any excuse will do in a bear market, and filings released yesterday containing data anywhere from 6 weeks t... https://seekingalpha.com/news/1028951?source=tweet\" data-url=\"https://seekingalpha.com/news/1028951\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}